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THE PURPOSE OF THIS THESIS
The QT interval, hitherto thought to be determined
largely if not solely by heart rate, has become the focus
of increased interest recently through the realization
that the QT interval also shortens during periods of
increased sympathetic nervous system activity under
circumstances where heart rate remains unchanged, such as
during exercise in fixed-rate ventricular pacing in
patients in complete heart block, and the successful use
of this principle by the TX pacemaker to provide a rate
response during periods of increased metabolic demand.
The aim of the first part of this thesis is to obtain a
better understanding of factors which affect the duration
of the QT interval.
Initially the error in estimating QT intervals is
calculated and an attempt is made to define 'normal
resting QT interval values.
The heart rate/QT interval during exercise is examined
to determine which regression equation provides the best
curve fit, which could then be used for comparison of data
presented subsequently in the thesis.
Heart rate/QT interval relation during atrial pacing at
rest is compared with exercise heart rate/QT interval
relations during exercise as any significant differences
between these two relations would indicate the importance
of factors other than heart rate which control the
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duration of the QT interval.
As some of the studies which are described in the
literature and in the thesis involve patients who are
paced ventricularly, the relations between paced-atrial
rate and QT interval and paced-ventricular rate and QT
interval are compared and the rate of adaptation of the QT
interval to changes in pacing rate is also examined during
ventricular pacing.
Studies to date which have examined the contribution of
factors other than heart rate to exercise-induced QT
interval shortening have relied on different groups of
subjects. Patients with atrial synchronized ventricular
pacemakers afford the opportunity of evaluating this on a
within-patient basis by exercising the same group of
patients during fixed-rate and atrial synchronized
ventricular pacing modes and examining the respective
atrial rate/QT interval and heart rate/QT interval
re la ti on .
Crucial to the success of the QT-responsive (TX) pacing
system is the extent to which the heart rate/QT interval
relation is subject to patient variation. The exercise
data in normal subjects and that in patients undergoing
atrial and ventricular pacing at rest are therefore
examined to determine the extent to which, if any, the
heart rate/QT interval relation varies in different
patients. Patients with implanted atrial synchronized
pacemakers also permits the quantification of
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inter-patient and intra-patient variation affecting the
contribution of heart rate to QT interval changes by
examining the data in patients who were exercised on more
than one occasion.
The role of heart rate and sympathetic nervous system
activity in determining the extent of changes in the QT
interval during exercise, is further examined by studying
the effect of beta adrenergic receptor blockade on the
atrial/QT interval and heart rate/QT interval changes
during fixed-rate and atrial synchronized ventricular
pacing modes, respectively. Heart rate/QT interval
relation is also examined in normal subjects before and
after acute beta adrenergic receptor blockade.
It has been suggested in the literature (Vaughan
Williams, 1975 and 1977) that the effects of acute and
chronic beta adrenergic receptor blockaded on the duration
of the QT interval vary. This may have important
implications in patients with TX pacing system who require
or are on beta blocker medication. The heart rate/QT
interval relation following acute beta adrenergic receptor
blockade is therefore compared with the heart rate/QT
interval relation during exercise in patients who are on
long term beta blocker therapy.
Any significant patient variation affecting the heart
rate/QT interval relation would render Bazett 's formula
invalid. Bazett 's constant QTc which corrects the
measured QT for changes in heart rate is therefore
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examined under circumstances where both heart rate and
autonomic nervous system activity act on the QT interval,
such as during exercise and the results are compared to
that in subjects in whom heart rate alone is altered, for
example during pacing, or who are beta blocked.
Both ventricular effective refractory period and QT
interval are affected by heart rate. This thesis
therefore addresses itself to the relations between heart
rate, QT interval and ventricular effective refractory
period and the effect of two class III antiarrhythmic
drugs, namely amiodarone and sotalol, on these relations.
The overall aim of the first part of this thesis is to
provide information on factors which govern the heart
rate/QT interval relations and hence obtain a greater
understanding of the performance of the QT-responsive (TX)
pacing system.
The second part of the thesis examines the whole concept
of physiological pacing and its advantages compared with
fixed-rate ventricular demand pacing.
The relative contributions of heart rate and atrio¬
ventricular synchrony to exercise performance are
discussed and in this exercise performances during rate
responsive (TX) pacing, fixed-rate and atrial synchronized
ventricular pacing modes are compared.
The paced-ventricular rate/Stimulus artefact to
5
T wave interval relation is compared with the heart
rate/QT interval and in particular is examined to
determine if it is also affected by patient variation.
The effect of alternating various programmable indices
on rate response during treadmill exercise tests is
defined and suggestions are made as to the best method of
programming this pacemaker and possible future
developments.
6
THE PLAN OF THIS THESIS
This thesis is divided into two major parts.
In the first part, an introductory review is given of
current knowledge concerning factors which determine the
duration of the QT interval and formulae which have been
proposed in the literature to correct the QT interval for
heart rate. An account is given of the methods used and
results achieved during the examination of the contributions
of heart rate and autonomic nervous system activity to QT
interval changes under various circumstances. The effects
of heart rate on QT interval and ventricular effective
refractory period are defined and the changes produced by
amiodarone and sotalol on the heart rate/QT/ventricular
effective refractory period relations are compared. The
first part is concluded by a discussion of the findings and
their probable relevance to the performance of the new
QT-responsive (TX) pacing system.
The second part of the thesis is introduced by a discussion
of physiological pacing and its reported advantages compared
to fixed-rate ventricular pacing. This is followed by a
description of methods used to quantify improvements in
haemodynamic indices and exercise performance during atrial
synchronized ventricular pacing mode compared to fixed-rate
ventricular pacing, examination of the role of the
chronotropic response to improvements in exercise
performance and the performance of the rate responsive TX
pacemaker. This is followed by sections which report and
discuss the findings.
PART ONE
QT AND RELATED INTERVALS
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ABSTRACT
The QT interval of the standard electrocardiogram is a
clinical measure of the action potential duration. Heart
rate has hitherto been regarded as its most important
determinant and Bazett 's formula QT = k yRR' Interval is
usually used to correct QT interval for differences in
heart rate.
In the first part of this thesis it is shown that the
heart rate/QT interval relation during exercise, can
equally satisfactorily be expressed by the linear
regression equation, QT = 494 - 1.581 x Heart Rate. QT
interval changes induced at rest by pacing;
QT = 433 - 0.99 x Heart Rate, were less than those seen
during exercise. Furthermore, QT interval shortened with
exercise during fixed-rate ventricular pacing;
QT = 515 - 0.85 x atrial rate. These studies suggest that
heart rate is not the sole determinant of exercise-induced
QT interval changes and that the autonomic nervous system
also plays a significant role in this respect.
QT interval was found to take about a minute to adapt
fully to changes in pacing rate. The slopes of linear
regression equations describing the paced-ventricular
rate/QT interval (broad QRS complexes) and paced-atrial/QT
interval relations were similar.
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The separate contributions of heart rate and factors other
than heart rate, to QT interval shortening during exercise
was assessed on a within-patient basis, by exercising
patients with atrial synchronized ventricular pacemakers
during atrial synchronized and fixed-rate ventricular
pacing modes. In each subject the QT interval shortened
with exercise fixed-rate ventricular pacing at 70 beats
per minute and in each case the QT interval shortening
during fixed-rate ventricular pacing was less than that
during atrial synchronized ventricular pacing mode. Only
about half of the QT interval changes could be attributed
to heart rate alone.
The contribution made by heart rate was subject to wide
inter-patient and intra-patient variation. Acute beta
adrenergic receptor blockade abolished the QT interval
changes with exercise during fixed-rate ventricular pacing
mode. Acute beta adrenergic receptor blockade also
reduced the slope of the heart rate/QT interval regression
line in subjects with normal conduction. Autonomic
nervous system activity therefore has an important role in
determining exercise-induced QT interval changes. Chronic
beta adrenergic receptor blockade however, had little
effect on the slope of the heart rate/QT interval linear
regression equation, presumably due to adaptive changes
affecting this relation and occurring at a cellular level.
QT interval prolongation may reflect a cardiac state with
greater than normal disparity of recovery times rather
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than one where simply prolonged recovery is present. This
inhomogeneity of recovery times may predispose to
arrhythmia susceptibility. Class III antiarrhythmic drugs
may act by reducing this inhomogeneity by having a greater
effect on cells with shorter recovery times. Ventricular
effective refractory:QT interval ratio may be a useful
index of homogeneity of myocardial recovery times. The
heart rate/ventricular effective refractory period/QT
relations were explored during pacing and the effects of
sotalol and amiodarone on these relations were studied.
Of the two drugs, amiodarone had the greatest effect on
ventricular effective refractory period compared to
changes in QT interval.
In the second part of the thesis it is shown that atrial
synchronized ventricular pacing improves exercise
performance in the vast majority of patients with stable
second or third degree atrio-ventricular block. This
enhanced exercise performance is due to the chronotropic
response to exercise rather than to the maintenance of the
proper sequence of cardiac chamber activation.
A new rate responsive pacemaker has been designed based on
the principles that sympathetic activity governs in part
QT interval changes and that heart rate changes contribute
significantly to haemodynamic adaptations to increased
physiological demand: the TX pacing system (Vitatron)
senses the T waves of paced-ventricular complexes and
alters heart rate in response to changes in the Stimulus-T
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interval. The TX pacemaker was implanted and its
performance evaluated in 14 patients. The effect of the
programmable indices: T wave sensitivity, slope and T wave
sensing window on rate responsiveness during exercise are
described. T wave sensing problems arose in 3 patients.
The TX pacemaker improved exercise performance in the
majority of patients and provided satisfactory rate
responses to varying physiological needs as assessed by
Holter monitoring. The paced-ventricular rate/Stimulus-T
interval relation at rest was subject to significant
inter-patient and intra-patient variation. Consequently,
the onset of rate response and the programmed upper heart
rate limit was attained at different stages of identical
exercise protocols. Repeated exercise testing and
programming changes were necessary to adjust for this
variation and to ensure that the pacemaker continued to
function optimally. Suggestions are made about possible
future developments of this pacing system.
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CHAPTER 1 INTRODUCTION
The QRST complex of the standard electrocardiogram
describes ventricular depolarization and repolarization.
The QT interval is thought to reflect the resultant of
action potential durations of all ventricular muscle
eel1s.
The QT interval has recently been the subject of
increasing interest, because of (a) the reported
association between prolonged QT intervals and serious
ventricular arrhythmias (Jervell and Lange-Nielson, 1957 ;
Romano et al., 1963; Ward, 1964; Krikler and Curry, 1976;
Ahnve et al., 1978; Ahnve et al., 1980; Taylor et al.,
1981; Palatini et al., 1984), the identification of QT
prolongation as a prognostic index of sudden death
(Schwartz and Wolf, 1978; Ahnve et al., 1980; Boudoulas et
al . , 1984 ), (b) the use of amiodarone and sotalol, which
have antiarrhythmic properties but which paradoxically
prolong the QT interval (Rosenbaum et al., 1976), (c) the
realization of the importance the autonomic nervous system
in determining the duration of the QT interval and (d) the
availability of the QT responsive (TX) pacing system.
Factors Affecting the Duration of the QT Interval:
Several factors are known to influence the duration of the
QT interval. Abnormalities of the QT interval have been
described in association with electrolyte disturbances
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(Lepeschkin and Suarawicz, 1952; Weidmann, 1956), drugs
(Pick, 1957; Kelly et al., 1963; Weber et al., 1972;
Reynolds, 1976), neurogenic mechanisms (Burch et al.,
1954), hypothermia (Clements and Hurst, 1972),
hypothyroidism (Surawicz et al., 1977) as well as cardiac
states such as mitral valve prolapse (Swartz et al.,
1977), myocardial ischaemia (Sareli et al., 1980),
myocardial infarction (Elek et al., 1953; Doroghazi and
Childers, 1978), use of liquid-protein-modified diets
(Isner et al., 1979; Siegel et al., 1981), anorexia
nervosa (Isner et al., 1985), drug-free depressed states
(Rainey et al., 1982) and pulmonary tumours (Petrovich et
al., 1978).
The Role of Heart Rate -
Historical Background:
Traditionally heart rate has been regarded as the most
important determinant of the QT interval and various
formulae have been proposed to take into account the
effect of heart rate on the measured QT interval.
Waller in 1891 was the first person to point to an inverse
relation between mechanical systole and heart rate.
Lombard and Cope (1919) confirmed from their studies on
the carotid pulse that the duration of mechanical systole
was inversely related to the square root of the pulse rate
mechanical systole = 60/k "\ypulse rate , where k was a
constant. The value of k for standing posture was 28.5,
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for sitting, 26 and for lying down, 25. Systolic times
were longer during exercise and in women. They postulated
that the latter finding may have been due to "the fact
that most women take little exercise"!
Formulae Proposed in the Literature to Correct the
Measured QT Interval for Differences in Heart Rate:
Bazett (1920), reported on 'electrical systole' as well as
'mechanical systole', values for the latter having been
borrowed from Weitz, 1918. He argued that as electro¬
cardiographic measurement of systole correlated well with
mechanical systole, a similar formula may be used to
describe the relation of heart rate and electrical
systole. He was able to find a hyperbolic relation
between electrical systolic times and cardiac cycle length
(Figure A) - Electrical Systole = k x ^Cardiac Cycle
Length. Of all the suggested correction factors his has
remained the most popular because of its simplicity.
As the QTc which corrects the measured QT interval for an
arbitary heart rate of 60 beats per minute: [QTc =
measured QT interval/kYfcardiac cycle length (seconds)] is
widely used for comparison of data, a more detailed
examination of the original data on which it is based is
called for: Bazett's data dealing with electrical systole
consisted of the following groups of subjects:
20 normal men; (28 values - heart rate; 34 to 105 beats
per minute);
Normal values for ventricular systole (electrical), the P-R interval, and the duration of the
Q.R.E. group in men, including also five observations on infants, which form the five restingvalues at the extreme left of the curve.
Electrical Systole . Keating •
»» l» After exercise o
P• R Interval . Keating ▲
»* »» After exercise &
Q.R*.S. Qrou-p .. Keating •
)» •» After exercise o
j- On the top curve.
On the lowest curve.
Figure a
relation.
Bazett's hyperbolic heart rate/QT interval
(Heart 1918-20, Volume VII, page 358).
14
19 normal women; (31 values; heart rate, 65 to 105 beats
per minute);
5 children aged 1 day to 2 months (heart rates; 114 to 198
beats per minute) and 16 'exercise QT values' in 3 men.
The formula which he provided apparently included all the
measurements on these cases, although this is not
definitely stated to be the case.
Despite its acceptance through common usage, Bazett's QTc
has therefore some serious obvious weaknesses, largely
resulting from the fact that the heart rate/QT interval
relation was derived from very inhomogenous data:
(i) The data included both resting and post-exercise
values.
(ii) Resting heart rates varied from 34 to
198 bpm (!).
(iii) There were no true exercise data, as he was unable
to record the electrocardiogram during exercise;
his 'exercise' values were recorded after 0.5 to
13 minutes rest and with only 8 'exercise'
heart rates being greater than 100 bpm.
(iv) No clinical information was provided about the
patients beyond their sex. In particular he did
not mention any drug therapy the subjects may have
been taking which could have affected the results.
Bazett himself was aware that his k was anything but
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constant under a variety of situations such as rest and
during exercise. He reported larger k values for women
(males, k=0.37; females, k=0.40) and suggested that this
reflected the effect of differences in heart size. In
support of this, he referred to studies by Meakins (1919),
which had shown that the duration of the electrical
systole was increased in patients with large hearts. But
as Bazett himself pointed out, Meakins' conclusions had
referred to mechanical systole and not the QT interval,
the relation between the two variables being different in
patients with diseased and enlarged hearts due to
differences in sympathetic activity (Wiggers, 1917).
Furthermore, mechanical systole is sensitive to afterload
but not the QT interval.
Other Proposed Correction Formulae:
That heart rate/QT interval relation was intrinsically
subject to patient variation which depended on factors
other than heart rate was apparently forgotten in the
following sixty years. During this period, attempts were
made to improve on Bazett 's formula (Table IA). Fenn
(1922), Cheer and Li (1930), Shipley and Halloran (1936)
and Hegglin and Holtzmann (1937) provided square root
formulae which approximated Bazett's. Fridericia (1920)
proposed a cube root formula, which was supported by other
workers (Miki, 1922; and Schlomka and Raab, 1936).
Staniforth (1983), using atropine, hyoscine and
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exercise to obtain a range of heart rates, proposed a
power formula which approximates to the cube root formula
of Fridericia (1920) as providing the best curve fit.
Mayeda (1934) also derived a power curve formula to
describe the cardiac cycle length/QT interval relation
whilst Adams (1936), Schlamowitz (1946), Rickards et al.,
(1979) and Rickards and Norman (1981) have reported that
this relation is essentially linear. Simonson et al.,
(1942) proposed a loglinear relation between QT interval
and cardiac cycle length. Ashman (1939 and 1942) and
Manion et al., (1980) have also reported that a
logarithmic formula is better than Bazett's formula at
correcting the measured QT interval for differences in
heart rate.
Apart from Bazett, other workers have noted that sex
(Cheer and Li, 1930; Adams, 1936 and Shipley and Halloran,
1936) and age (Schlomka and Raab, 1936 and Simonson et
al., 1942) or both (Ashman, 1939 and 1942 and Ashman et
al . , 1945), had a small but significant effect on the QT
interval.
Many of these studies contain experimental bias that limit
their value. In particular most of the equations are
derived from data towards which each subject has often
made only a single contribution. The heart rate/QT
interval relation has not been analysed in any detail on a
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within-patient basis. The equations may be relevant in
comparing inter-population QT interval changes. They
cannot be applied freely to situations where QT interval
changes are studied in individual subjects or have been
brought about by therapeutic manoeuvres.
The Effect of Autonomic Nervous System Activity on the
Duration of the QT Interval:
Bazett in his classic paper (1920), draws attention to the
"importance of the action of the vagus and sympathetic".
He refers to the work of Hunt (1899) who "found that the
vagus affected both systole and diastole, but the latter
to a larger extent, while sympathetic stimulation caused
greater changes in the duration of systole in proportion
to the change in pulse rate", and the work of Patterson
(1915), who had shown that adrenaline infusion caused a
"lessening of k". His own results, which were based, as
observed, on very limited data, indicated an increase in
the value of k after exercise which he explained on the
basis of "an absence of the normal balance between vagal
and sympathetic activity".
Other workers have also noted that the heart rate/QT
interval relation varies widely and consequently heart
rate could not explain all the changes in the duration of
the QT interval.
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Ashman (1942) for instance reported that this relation in
an individual patient varied when changes in heart rate
were brought about by exercise from which occurred as
consequence of a paroxysmal tachycardia. Simonson et al.,
(1942) discovered that although within the upper limits of
normal, the various correction formulae provided similar
QT intervals, a wide scatter existed when QT values were
correlated with heart rate. He was unable to explain the
variation in the QT interval in spite of analysing a host
of factors with the aid of a computer. Only age appeared
to make a small contribution. Geppert (1949) also
analysed the relation between heart rate and QT intervals
using linear and exponential formulae based on data
derived on 600 occasions from one healthy individual. The
variation of the 'constants ' for both formulae were
enormous.
More recently, Manion and his colleagues (1980) have also
emphasized the disparate nature of the heart rate/QT
relation which they studied in eleven subjects - in one
individual there were marked changes in the QT interval at
nearly the same heart rate, but in another individual, the
QT interval remained invariate through marked changes in
heart rate. A similar observation has been made by
Anderson (1981), who noted that, in children who
demonstrated marked sinus arrhythmia, the uncorrected QT
interval remained stable despite wide excursions in heart
rate resulting in wide variations in the QTc.
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These studies have been extended to show that QT interval
changes during pacing at rest are less than those which
occur during exercise. Rickards et al., (1979) compared
the heart rate/QT interval relation in 3 groups of
patients:
Group 1. Ten patients who were not on any medication
which would be likely to affect the QT interval and who
underwent maximal exercise tests. The results were
initially reported as follows;
Heart Rate (bpm) = -0.45QT(ms) + 248 (r= 0.83), otherwise
expressed as, QT (ms) = 551 - 2.22 x Heart Rate (bpm).
The QT interval changes during exercise therefore appeared
to be sensitive to small alterations in heart rate.
Group 2. Fifteen patients who were on beta adrenergic
receptor blocking drugs and who also underwent maximal
exercise tests. There was no significant difference
between the slopes of the linear regression equations
describing the heart rate/QT interval relations in groups
1 and 2.
Group 3. Fifteen patients who underwent an atrial pacing
stress test in the cardiac laboratory. In this group of
patients the authors did not record any change in QT
interval and they therefore concluded that heart rate per
se had no effect on the QT interval.
In a reappraisal of their data (Rickards and Norman,
1981), the following linear regression equations were
provided to describe the heart rate/QT interval relations,
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presumably for the same group of subjects:
QT (ms) = 522 - 1.87 x Heart Rate (Groups 1 and 2) and
QT (ms) = 399 - 0.66 x Paced-Atrial Rate (Group 3),
(Figure B).
Hence, two-thirds of the QT interval shortening during
exercise could not be explained on the basis of an
increase in heart rate.
In support of these findings a fourth group of patients in
complete heart block with implanted ventricular pacemakers
were exercised. Despite a constant ventricular rate, the
QT interval did shorten with exercise. Furthermore, a
close correlation existed between the independent atrial
rate and the QT interval changes:
QT = 530 - 0.95 x Atrial Rate (n = 9). They presumed that
there was no autonomic innervation of ventricular
myocardium and hence concluded that most of the QT
interval changes during exercise were brought about by
circulating catecholamines. No mention was made about the
heart rate/QT interval relation in individual subjects.
In a series of similar studies, Milne et al. (1980)
examined the heart rate/QT interval relation during atrial
pacing at 3 rates at rest - 100, 130 and 150 beats per
minute - during ventricular pacing at 2 rates at rest - 88
and 138 beats per minute, and during exercise at a
fixed-ventricular rate. The respective approximate linear
regression equations were as follows;
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21
QT (ms) = 548 - 1.22 x Paced-Ventricular Rate (bpm) and
QT (ms) = 481 - 0.61 x Paced-Ventricular Rate (bpm).
Their conclusions were also that sympathetic nervous
system activity did shorten the QT intervals during
fixed-rate ventricular pacing but their results suggested
that the role of sympathetic nervous system was less
important than heart rate in determining the duration of
the QT interval.
A different approach has been to evaluate the contribution
of the autonomic nervous system to QT interval changes by
studying the effect of atropine and beta blockers to
patients during fixed-rate atrial pacing. Browne et al.,
(1982) have reported that atropine shortened the
atrially-paced QT interval but that propranolol had no
effect in this respect. Atropine plus propranolol
shortened the atrially paced QT interval from 330 + 28 ms
to 315 + 27 ms. Ahnve et al., (1982) have also reported
that for identical paced-rates, propranolol had no effect
on the duration of the QT interval. They also found that
the addition of atropine shortened the QT interval. These
studies suggest that at rest sympathetic nervous system
activity does not determine the duration of the QT
interval and furthermore that the cholinergic nervous
system has a direct effect on ventricular myocardium and
QT interval.
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Anatomic Basis for the Influence of Autonomic Nervous
System on the QT Interval;
The heart is profusely innervated by sympathetic and
parasympathetic divisions of the autonomic nervous system,
which contain both afferent and efferent fibres (Levy and
Martin, 1979).
The efferent pre-ganglionic sympathetic fibres emerge from
the spinal column through white rami communicantes of the
upper six thoracic segments to synapse about cells in the
upper thoracic and cervical ganglia.
From these, post-ganglionic fibres emerge to form the
sympathetic cardiac nerves.
The efferent cardiac parasympathetic nerves are derived
from the dorsal nucleus of the vagus and from cells near
the nucleus ambiguus and run in the cardiac branches of
the vagus to synapse about cells in intra cardiac ganglia,
usually close to structures innervated by post-ganglionic
neurons.
Until recently the view was held that there was no vagal
innervation of the mammalian ventricles (Sarnoff and
Mitchell, 1962). Since then considerable evidence has
accrued to support the concept of an appreciable vagal
innervation of the mammalian ventricles (Duchene-Marullaz,
1973; Higgins et al., 1973; Levy, 1976; Levy and Martin,
1979). Choline acetyl tranferase, the enzyme that
catalyzes the production of acetyl choline in
parasympathetic nerves and muscarinic cholinergic
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receptors has been shown to be present in mammalian
ventricle (Schmid et al., 1978; Fields et al., 1978) and
nerves that stained for acetylcholinesterase have been
found in ventricular myocardium (Kent et al., 1974).
Vagal efferent nerves approach the heart over the
posterior atria and may reach the ventricular myocardium
via the ventricular septum as well as the epicardium
(Hirsch, 1971).
(i) Adrenergic Effects:
The effects of catecholamines are mediated through beta
receptors located at the outside of the cell membranes
(Reuter, 1974). Beta receptor activation may operate
through an increase in cyclic AMP. This in turn is
believed to activate a protein kinase (Reuter, 1974 and
1976; Fozzard, 1981) which catalyzes the phosphorylation
of proteins associated with Is^ channels and the
sarcoplasmic reticulum (Watanabe and Besch, 1974; Tada et
al., 1975). In this way the number of Ca++ channels are
increased. In sarcoplasmic reticulum membranes protein
phosphorylation leads to an increase in Ca++-ATP-ase
activity and Ca++ uptake by the organelles and thus to an
increase in the rate of relaxation.
In sino atrial cells, catecholamines increase the rate of
diastolic depolarization (hence the chronotropic effect),
increase the maximal rate of depolarization, elevate the
plateau height and slightly shorten the action
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potential duration (Carmaliet, 1982). Catecholamines also
increase the plateau amplitude and shorten the action
potential duration and refractory period of Purkinje
fibres (Wit et al., 1979; Zipes et al., 1981; Carmaliet,
1982 ) .
Zipes et al. (1981), report that beta adrenoreceptor
stimulation has little effect on ventricular action
potential. Conversely, catecholamines are reported to
lengthen or shorten the action potential, depending on the
type of substance and its concentration (Quadbeck and
Reiter, 1975 and 1975; Wit et al., 1979). Shortening of
the action potential due to sympathetic stimulation is
believed to be mediated through an increase in the K+
current (Noble and Tsien, 1965). Intracellular studies
have shown that ganglion blocking agents prolong the
action potential, presumably by decreasing the amplitude
of the K+ channels in the membrane (Ito and Surawicz,
1981). Drugs that block the function of postganglionic
adrenergic nerves have similar effects on myocardial
repolarization. The prolongation of the repolarization
phase of the ventricular action potential by bretylium
tosylate has been well shown in vitro by Bigger and Jaffe,
(1971). Similarly, bethanidine increases the duration of
the ventricular action potential - the 'evoked response'
(Donaldson and Rickards, 1982).
Adrenergic stimulation has been also been reported to
shorten the ventricular refractory period
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(Brookes et al., 1955; Reddy and Gettes, 1979). Beta
blockade, however, has been shown to shorten only
insignificantly the duration of the right ventricular
effective refractory period (Prystowsky et al., 1980).
The influences of the sympathetic nerve stimulation on the
heart are modulated by cholinergic activity and are hence
dependent to some extent on vagal innervation.
Furthermore the effects of the right and left sympathetic
nerves on ventricular refractory period are not uniform
over large areas of both ventricles (Moore and Swain,
1960; Yanowitz et al., 1966; Kralios et al., 1975). This
dispersion of refractoriness may provide one mechanism by
which sympathetic neural output might result in
ventricular arrhythmias.
The QT interval also prolongs following left stellate
ganglion stimulation or interuption of the right stellate
ganglion (Yanowitz et al., 1966). The long QT syndrome
(Jervell and Lange-Nielson, 1957; Romano et al., 1963;
Ward, 1964) , an inherited defect which causes some
children to faint during exercise or emotional states
associated with a prolonged QT interval and sometimes an
alternating T-wave and a predisposition to ventricular
fibrillation, may result from a congenital imbalance in
cardiac sympathetic innervation, characterized by reduced
right sympathetic activity and/or enhanced activity of the
left stellate ganglion (Yanowitz et al., 1966; Moss and
McDonald, 1971; Crampton, 1979).
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(ii) Vagal Effects;
There are several examples of cholinergic-adrenergic
interaction (Levy, 1977), notably (a) interneural e.g.
presynaptic muscarinic inhibition of noradrenaline release
by sympathetic nerve endings and (b) intracellular -
muscarinic agonists modulate the effects of beta agonists
through inhibition of beta-induced activation of
adenylcyclase (Gardner 1976; Watanabe et al., 1978 and
1978; Muscholl, 1982).
Vagal effects on ventricular action potential duration and
recovery of excitability are not settled.
Vagal stimulation has been shown to prolong ventricular
effective refractory period by antagonizing sympathetic
activity via muscarinic receptors (Zipes et al., 1981).
The magnitude of vagal effects on the ventricular
effective recovery would therefore be expected to be
accentuated in the presence of increased sympathetic
activity (Zipes et al., 1981). Ventricular effective
refractory period is also shortened by intravenous
atropine (Prystowsky et al., 1981; Browne et al., 1982).
Thus the evidence currently suggests that resting vagal
tone exerts a significant effect on human right
ventricular refractoriness and that this effect can occur
during beta adrenergic blockade (Zipes et al., 1981).
Vagal-induced prolongation of the ventricular effective
refractory period may be one mechanism by which
27
cholinergic stimulation may terminate a ventricular
tachycardia (Waxman and Wald, 1979).
The resting parasympathetic tone affects the QT interval
directly in man and withdrawal of the vagal tone shortens
the QT interval (Browne et al., 1982; Ahnve et al.,
1982 ) .
Martins and Zipes (1980) studied the effect of right and
left vagal nerve stimulation on the QT intervals measured
from nine separate ventricular sites and found QT
prolongation at all sites except the anterior right
ventricle. This correlated with the effective refractory
period measured at the same sites. This nonuniform
response to vagal stimulation may result from unequal
distribution of vagal or sympathetic innervation or
unequal electrophysiological responses to autonomic
influences and could play a role in the genesis of some
arrhythmias (Zipes et al., 1981).
Electrophysiological Basis for the Heart Rate/Systolic
Time Interval Relation:
It has been known for some time that an increase in heart
rate is accompanied by an abbreviation of systolic time,
thereby ensuring adequate time for diastolic filling of
the ventricles. This is partly due to a purely
rate-dependent shortening of the action potential (Hoffman
and Cranefield, 1960; Boyett and Jewell, 1978) and partly
to the action of adrenaline on the myocardium
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(Morad et al., 1972). Experiments on mammalian cardiac
muscle have shown that cathecholamines not only cause a
rate dependent shortening of the action potential but also
abbreviate systole by enhancing the rate of myocardial
relaxation through an action which is independent of heart
rate (Boyett and Jewell, 1978).
The electrolyte currents responsible for the production of
the action potential are illustrated in Figure C. The
duration of the action potential depends in part on the
processes responsible for repolarization of the cell
membrane. The factors which are believed to be involved
in this process are:
1. Inactivation of the slow inward current.
2. Growth of the outward current.
3. Return of K+ conductance (inward rectification).
Repolarization is then followed by a period of membrane
recovery during which the slow inward current recovers
from inactivation and the outward current decays to
resting values.
Increased rate of myocardial stimulation may interfere
with the processes of repolarization and membrane recovery
and thereby shorten the action potential by several
mechanisms (Vaughan Williams, 1980):
1. Triggering of an action potential before the recovery
phase is complete may reduce the amount of slow
inward current that can be activated (Gettes et al.,
TIME (ms)
Figure C . Electrolyte currents responsible for
the production of the action potential.
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1974). Furthermore the outward current may not have
had time to decay fully (de Hemptinne, 1971;
Hauswirth et al., 1972).
2. Accumulation of Ca++ intracellularly may reduce
the electrochemical gradient for the slow inward
current (Reuter, 1973), or increase the outward
current through an action on the K+ membrane
permeability (Meech, 1976; Bassingthwaigthe et al.,
1977; Gelles, 1977; Isenberg, 1977).
3. Accumulation of K+ in the extracellular clefts
(Noble and Tsien, 1965; Kline and Morad, 1976).
The relative importance of these mechanisms in causing a
rate-dependent shortening of the action potential is as
yet ill defined. However, mechanisms 2 and 3 are believed
to play a greater role in contributing to action potential
reduction at rates in excess of 100 beats per minute
(Vaughan Williams, 1980).
The Effect of Beta Adrenergic Receptor Blockade on
the QT Interval;
(i) Acute Versus Chronic Beta Adrenergic Blockade;
It is now believed that the secondary effects of prolonged
beta-adrenoreceptor blockade can be distinguished from the
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acute effects. Microelectrode studies of rabbit cardiac
muscle (Vaughan Williams et al., 1975; Vaughan Williams,
1978) have shown that prolonged beta-blockade
significantly prolonged action potentials in animals, in
contrast to the absence of acute beta-blockade action on
cardiac action potential duration. The QT interval
steadily lengthens after a week, reaching a plateau at 3
to 4 weeks. Similar observations have been made in man.
Seides et al., (1974) reported that intravenous
propranolol had no effect on the duration of the QT
interval.
Chronic treatment with beta-blockers has been reported to
cause a relative prolongation of the QT interval (Raine
and Pickering, 1977). Edvardsson and Olsson (1981) have
also shown that prolongation of monophasic action
potential duration occurs with chronic but not acute
administration of metoprolol.
Adaptation of the Heart Rate/QT Interval Relation to
Prolonged Beta Adrenergic Blockade:
Vaughan Williams (1980) noted that prolongation of the
action potential due to chronic beta blocker therapy
persisted after cessation of treatment. He distinguished
the therapeutic response and QT interval changes due to
prolonged beta adrenergic blockade while patients were
still taking the drug from 'adaptation' to treatment i.e.
from effects which persisted after treatment had been
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interrupted for a sufficient length of time to permit all
drugs to be eliminated from the body.
As part of their studies Vaughan Williams et al., (1980
and 1982) recorded the electrocardiogram in a group of
normal subjects at rest and during exercise, before and
after intravenous beta blocker therapy [Cardioselective
drugs; atenolol (5mg) and metoprolol (10 mg) and
non-selective drugs; pindolol (0.4 mg) and propranolol (1
mg)]. The subjects were subsequently put on the
corresponding oral preparations of beta blocker therapy
for four weeks, (total daily dose: 100 mg atenolol, 200 mg
metoprolol, 15 mg pindolol and 160 mg propranolol,
respectively). The electrocardiogram was re-examined at
rest and on exercise 52 hours after the last dose of beta
blocker drugs.
The heart rate responses while the subjects were taking
the drug were different in the two groups. In the
cardioselective group there was a significant bradycardia
at rest which was absent in the non-selective group.
Adaptation to prolonged beta-adrenoreceptor therapy was
also different in the two groups; the resting and exercise
heart rates were lower after 52 hours of cessation of
treatment with the cardioselective drugs but a similar
effect was not seen with the non-selective drugs.
Adaptations in the heart rate/QT interval relation were
also observed with the cardioselective drugs. (The QT
interval was expressed as a function of the R-R interval
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using linear regression equations. For the sake of
simplicity the QT intervals are expressed as a function of
heart rate here). Table IB and Figure D show the results
in the two groups of patients.
Their interpretation of these results was that no
'adaptation' of the heart rate/QT interval relation had
occurred after 4 weeks with the non-selective drugs
although the QT interval had prolonged by 16 ms. On the
other hand the slope of the heart rate/QT regression had
flattened at rest and on exercise with the selective beta
adrenergic blockers.
Although there was a considerable flattening of the slopes
of the regression equations after acute beta adrenergic
blockade at rest and to a much smaller extent during
exercise with the non-selective drugs, it is difficult to
understand why a similar change in the heart rate/QT
interval relation was not seen during exercise with the
cardioselective drugs. The equations also surprisingly
suggest that the QT interval shortened at the lower heart
rates after acute beta adrenergic blockade with both types
of drugs.
Rickards and Norman (1981) had also studied the heart
rate/QT interval relation during exercise in patients who
were not on any beta blockers and in patients who were
taking propranolol chronically. They did not observe any
difference in the slopes of the regression equations of
the two groups. To reconcile this finding with their
Figure D. The effect of beta adrenergic receptor
blockade on the heart rate/QT interval
relations based on the observations of
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belief that the sympathetic activity accounted for most of
the changes in the QT interval during exercise, they
advanced the explanation that the 'effect of propranolol
in blocking the sinus response to circulating
catecholamines is accompanied by a similar blocking of the
effect of circulating cathecholamines on repolarisation
time (QT interval) of the ventricular myocardium' (Akhras
and Rickards, 1980). Closer examination of this
statement, however, shows that this hardly explains why
over even a small range of heart rate changes during
exercise (such as that which occurs after beta blockade)
the QT interval should shorten so rapidly if heart rate
per se is not an important factor in influencing changes
in the QT interval, the effect of the sympathetic nervous
system activity having presumably been totally blocked.
Adaptation to Beta Blocker Therapy:
Two distinct factors have been postulated which may
control the relation between heart rate and QT interval
(Vaughan Williams, 1980);
1. A 'metabolic' factor, perhaps related to the level
of intracellular glycogen and glycolytically-
produced sub-sarcolemmal ATP (Cowan and Vaughan
Williams, 1977 and 1980). The availability of this
factor could be a function of the level of beta-
adrenoreceptor activation.
2. A 'biophysical' factor, purely related to heart
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rate, and under the control of the time-and-voltage
'gating' of the ionic channels.
It is proposed (Vaughan Williams, 1980) that acute beta
adrenergic receptor blockade, or adaptation to prolonged
beta adrenergic receptor blockade, could attenuate the
metabolic factor, leaving the rather feeble regression of
the rate-dependent biophysical factor.
Heart Rate/Ventricular Effective Refractory Period/QT
Interval Relations:
Introduction:
The QT interval is thought to reflect the sum of the
action potential durations of all ventricular muscle
cells. In common with the QT interval, ventricular
refractoriness is influenced by heart rate (Mendez et al.,
1956). A covariation has also been described between QT
interval duration and the refractoriness of ventricular
myocardium (Guss et al., 1976). However, the relation of
QT interval and ventricular recovery time is complex in
that factors which alter recovery time may result in
paradoxical effects on the QT interval (Lewis and Drury,
1926; Hoffman, 1960; Janse et al., 1969; Denes et al.,
1974). For example, left stellate ganglion stimulation
which frequently results in prolongation of the
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QT interval, reduces the refractory period in the
innervated area (Janse et al., 1969; Denes et al., 1974).
This suggests that prolongation of the QT interval may
sometimes reflect a cardiac state with greater than normal
disparity of recovery times rather than one in which
simply prolonged recovery is present. The degree of
inequality of recovery times in cardiac muscle has been
documented as a possible factor in arrhythmia
susceptibility (Drury, 1936; Mendez et al., 1956; Bigger
and Heissenbuttel; 1969; Spear et al., 1973; Castellanos
et al., 1973; Castellanous et al., 1973; Guss et al.,
1975; Kastor et al., 1975). Increases in the ratio
'effective refractory periodraction potential duration'
have been observed when antiarrhythmic drugs are
administered, and have been suggested to be an important
feature of the effectiveness of such drugs (Bigger and
Heissenbuttel, 1969). Preliminary studies in patients
support some of these in vitro findings (Guss et al., 1975
and 1976). The present study examines the relations of
ventricular effective refractory period and the QT
interval to changes in heart rate induced by pacing. The
heart rate/QT interval/ventricular effective refractory
period relations were also explored following
administration of amiodarone and sotalol - drugs with
reputed Class III antiarrhythmic properties.
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Amiodarone:
Amiodarone is very effective in the treatment of atrial,
junctional and ventricular tachyarrhythmias (Dreifus and
Ogawa, 1977; Fidelle et al., 1976; Wheeler et al., 1979;
Kaski et al., 1981). Its antiarrhythmic properties are
principally due to prolongation of the transmembrane
action potential duration and hence refractory period of
myocardial contractile fibres (Olsson et al., 1973; Coumel
et al., 1978; Fananapazir et al., 1984) and the
specialized conducting system (Cabasson et al., 1976;
Rosenbaum et al., 1974; Wellens et al., 1976; Nadamanee et
al., 1982). Amiodarone also exerts a non-competitive
beta-receptor blocking effect (Charlier, 1970; Singh and
Vaughan Williams, 1970). Its advantage over many other
antiarrhythmic agents resides in its extreme
effectiveness, long half-life which facilitates patient
compliance and the absence of any significant negative
inotropic effect.
Sotalol:
Sotalol was initially described as a pure beta adrenergic
antagonist with class II antiarrhythmic action, but
lacking cardioselectivity, intrinsic sympathomimetic
effect, or local anaesthetic properties (Lish et al.,
1965; Fitzgerald, 1969; Vaughan Williams, 1970).
Subsequent animal investigations have shown that sotalol
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also increases the action potential duration, similar to
that seen with amiodarone (Singh and Vaughan Williams,
1970; Strauss et al., 1970). Edvardsson et al., (1980)
also noted prolongation of right ventricular monophasic
action potentials in man and recently Bennett (1982) and
Nathan et al. (1982) have reported prolongation of the
atrial (AERP) and ventricular (VERP) refractory periods.
These effects are consistent with class III action
(Vaughan Williams, 1970).
The effect of intravenous (0.4mg/Kg) sotalol on the VERP
and the QT interval in the study of Nathan et al., was a
follows:
VERP prolonged from 231+30 ms to 242+31 ms (by 11 ms)
AERP prolonged from 216+38 ms to 233+40 ms (by 17 ms).
The atrially-paced QT interval prolonged from 388+43 ms
400+37 ms (i.e. by 12 ms)
Bennett (1982) measured the refractory periods 10 to 20
minutes after completion of an infusion of 1.5 mg/kg
sotalol, given over 5 minutes:
VERP prolonged from 209+23 ms to 245+20 ms (36 ms)
AERP prolonged from 224+37 ms to 264+49 ms (40 ms)




The literature indicates that both heart rate and
autonomic nervous system affect the duration of the QT
interval for which there appears to be good anatomical and
physiological bases.
The first part of this thesis addresses itself to
examining in greater detail factors which determine the
duration of the QT interval and the related ventricular
effective refractory period and the effect of certain








































































































































































































































































































































































































































































CHAPTER II PATIENTS AND METHODS
QT-INTERVAL MEASUREMENT
Accurate measurement of the QT interval is hindered by
several factors including observer variation. The onset
and termination of electrical activity of the surface
electrocardiogram is dependent on the lead recorded. The
onset is earliest in leads and the termination is
usually latest in the Standard limb lead II (Lepeschkin
and Surawicz, 1952).
Recordings of a single lead may give differences of
duration of the QT interval as great as 40 ms, as
alterations in the T wave vector may masquerade as changes
in the QT interval. Wherever possible, therefore, 3 more
or less orthogonal leads were recorded.
Care was taken not to include QT intervals of QRS
complexes of different widths in the same data. The same
set of leads was used in any particular patient or study.
Measurements were made using the lead with the longest QT
interval and the most distinct termination of the T wave.
The QT interval was measured using a pair of dividers,
from the onset of the q wave or the R wave in the absence
of a q wave, or the pacing artefact during ventricular
pacing to the termination of the T wave, i.e. the point
where the downslope of the T wave met the isoelectric
baseline (Figure 1A-C), (Ashman, 1942 and 1947;
Lepeschkin, 1951). The mean of 4 estimates of each QT
Figure 1. Examples of QT intervals of normal QRS
complexes, measured at a paper speed of
25 mm per second (A), 50 mm per second (B),
and pre- and post-exercise at 25 mm per
second (C); QT interval of ventricularly~
(D) and atrially-paced (E) complexes,
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Figure 2. Examples of QT intervals which were
unsatisfactory for measurement.
A - Collision of P waves with the terminal
portion of the T wave.
B - Prominent U waves.
C - biphasic T wave.
D - unstable baseline.
iSSURE-SCRIBE® RECORDING © marq
3UETTE ELECTRONICS, INC., 1978 MILWAUK^
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interval was used in calculations.
At high pacing rates, the pacing artefact (or the
resultant p wave during atrial pacing) may fuse with the
preceding T wave, thereby rendering impossible any
measurement of the QT interval. This was overcome by
switching off the pacemaker and measuring the QT interval
of the last of a sequence of paced-complexes (Figure ID).
The following circumstances were regarded as
unsatisfactory for QT interval measurements (Figure 2):
1. Presence of complexes where p or U waves obscured the
terminal portion of the T wave.
2. Presence of notched, bifid, biphasic, flat or
inverted T waves.
3. Presence of complexes with indistinct terminal
portion of the T wave.
4. Presence of muscle tremor or irregular baseline.
Paper Speed:
Except were indicated, QT intervals were measured at paper
speeds of 50 or 100 mm per second, (mostly on a six-
channel electrocardiographic recorder, Mingograph,
Siemens).
Exercise data presented in Sections C, E and F were
recorded using a Marquette CASE Computer Assisted System
for Exercising (MFG Milwaukee Marquette Electronics).
This system provided only a paper speed of 25 mm per
second. QT interval measurements were facilitated by the
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provision of a stable baseline. Precision of measurement
may be more difficult when assessing the QT interval with
electrocardiographic recordings at a paper speed of 25 mm
per second than at higher rates (Ahnve et al., 1978 and
1980; Crampton, 1979). However, QT interval measurements
at a paper speed of 25 mm per second have also been used
in larger studies (Haynes et al., 1978; Doroghazi and
Childers, 1978; Schwartz and Wolf, 1978) without
methodological problems. An advantage of this lower speed
is the acute angle with which the T wave meets the
isoelectric line. This end point often merges
imperceptibly with the baseline at paper speeds of 100 mm
per second.
Statistics
Regression Equations - Curve Fitting:
The following regression equations were used to express
the relation between two variables e.g. heart rate and QT
interval:
Linear regression line; y = a + bx
K V
Exponential regression curve; y = ae
Logarithmic regression curve; y = a + b.ln.x
Power curve; y = ax*3
The correlation coefficient r is an index of the extent to
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which the relation between the two variables x and y
approaches the extreme situation in which every point on
the scatter diagram falls on a straight line. It
therefore indicates the quality of fit of each of the
regression equations.
The linear regression describing the rate/QT interval
relation for a group of subjects in whom the rate/QT
interval relation had been determined individually, was
calculated by estimating the mean QT interval over a range
of heart rates, as predicted by the separate linear
regression equations and deriving the rate/mean QT
interval linear relation.
Correlation between two variables was also tested
non-parametrically using Spearman's Correlation Test.
Significant Differences between paired-numbers were
calculated using Wilcoxon's Signed Rank test and for
non-paired numbers using Wilcoxon's Sum Of Ranks Test.
The Significance of the Difference in the Slope of
Two Linear Regression Lines:
The significance of the difference between the slopes of
two linear regression lines was calculated as follows: let
Sy] be the standard error of the estimate for line 1,
based on n pairs of observations, and S^2 be the
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standard error of the estimate for line 2, based on n
pairs of observations,
(a) Calculate s2 = [ (n - l)Sy-|2 + (n - l)Sy22]
nl + n2 - 2
(b) Calculate standard error of the estimate of slopes
(bx - b2):
SE(b-, - b-}) = s / 1 + 1
V £(x - x) *• £(x - x)*
I
N.B. f(xi - x)2 = IxJ - (Ix^)2
i-i '* i
and
(c) Test b-j_ versus b2: t(n^ + n2 - 2) = bn - h0
SE (bx - b2)
(A) . Intra-Observer Error:
The intra-observer error of the QT interval measurements
was estimated from the exercise data, as these were most
likely to yield the largest intra-observer variation.
Forty random QT interval measurements performed several
months earlier were repeated without knowledge of the
original estimates.
The estimate of within-subject (intra-observer) variance=
C52 = £x2 + Xy2 - Z(X-!Y)2 -r n
I
Where X and Y are respectively, estimates of the QT
interval made on the first and second occasions and n =
number of estimates per occasion.
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Coefficient of intra-oberver error = (J x 100 (%)
Mean
Where mean = £(X+Y)
2n
JB)• __ Heart Rate/QT Interva1 Relation During Exercise
- Curve Fitting:
The electrocardiographic recordings of 14 patients (age;
28 to 61 years, 10 males) who had undergone a treadmill
exercise test as part of their investigations for
suspected but unproven ischaemic heart disease, were
examined. The electrocardiogram was normal in all
subjects. None of the patients was on any medication.
Correlation coefficients of linear, exponential,
logarithmic and power curve regression equations
describing the exercise heart rate/QT interval relation
were compared.
(C). "Normal Resting QT Interval":
Resting QT interval values were examined in 2 studies:
(i) Recordings Made After a Period of Rest in Patients
with Normal Atrio-Ventricular Conduction:
The electrocardiogram was recorded in the supine position,
at 5 minute intervals, after at least 2 hours of bed rest
in a quiet room. A total of 122 electrocardiographic
recordings were made in 10 subjects (aged 34 to 65 years,
7 males). The electrocardiogram was normal in all
subjects. One subject had received a mild sedation
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(valium 5mg) 2 hours prior to the study. None of the
remaining subjects was on any medication.
(ii) Electrocardiographic Recordings Made Puring Sleep
in Patients with Normal Atrip-Ventricular Conduction:
Two electrocardiographic recordings, separated by an
interval of 15 minutes, were made in each of 12 subjects
during deep slumber of at least 30 minutes duration. Six
subjects had received a mild sedation (5mg to lOmg
valium). Subjects with abnormal resting
electrocardiograms were excluded from the study.
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(D). Heart Rate/QT Interval Relation During Exercise:
Patients and methods were as described in section B.
(E-i And E-ii). Comparison of Resting Paced-Atrial
Rate/QT Interval and Paced-Ventricular Rate/QT Interval
Relations:
Eleven patients, aged 56 to 72 (mean 63) years, underwent
atrial and vetricular pacing in the coronary care unit, at
rates of 60 to 170 bpm, in increments of 5 to 10 bpm.
Seven patients were being paced for sinoatrial disease and
4 patients were under investigation for suspected
ischaemic heart disease.
(E-iii) The Rate of Adaptation of the QT Interval to
Changes in Ventricular Pacing Rate:
The rate at which the QT interval adapts to a lower
paced-ventricular rate was estimated in 6 patients
(aged 56 to 77 years; 3 males) with third degree
atrio-ventricular block who were awaiting implantation of
a permanent pacing system and who were not on any
medication. The studies were performed in a quiet room in
the supine position. Right ventricular pacing was
performed via a temporary electrode, at a rate of 110
beats per minute (bpm), for 10 minutes. At the end of
this period, the electrocardiogram was recorded at a paper
speed of 50 mm per second for 15 seconds and pacing then
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suddenly switched to a rate of 50 bpm whilst recording the
electrocardiogram continuously for a further 5 minutes.
The QT intervals of complexes just before the change in
heart rate and of consecutive complexes thereafter were
measured.
(F). Contribution of Heart Rate to QT Interval
Shortening During Exercise:
Twenty four patients with implanted atrial synchronized
ventricular pacemakers (Cordis models 208A and 308A) were
studied. Their ages ranged from 20 to 76 (mean 47) years;
14 patients were male. None of the patients was receiving
medication. Maximal exercise testing was performed on a
treadmill using the Bruce protocol (Bruce, 1971), with the
pacemaker programmed to one or another of two pacing modes
selected randomly;
(1) fixed-rate ventricular pacing at 70 bpm (V00) and
(2) atrial synchronized ventricular (VAT) pacing mode.
The pacemaker was then reprogrammed to the other pacing
mode and the exercise repeated after at least 30 minutes
res t.
In individual patients, the contribution of factors other
than heart rate to the total QT interval shortening during
exercise was estimated by comparing the slopes of their
regression equations describing the atrial rate/QT
interval relation in the V00 and VAT pacing modes:
48
QT interval shortening at atrial rates of and X2 during
V00 pacing mode
v= a-^ - b^.Xj_ minus a^ - b2.x2
= b1(x2 ~ x-l )
Similarly, QT shortening at a heart rate of x^ and X2
during VAT pacing mode
= a2 - b2-X"L minus a2 ~ ^>2'x2
= b2(x2 - xx)
Hence for a given increase in atrial rate from x^ to x2,
the QT interval shortening during V00 mode pacing (due to
factors unrelated to heart rate), compared with that
during VAT pacing mode and for a similar change in atrial
rate (due to all factors), equals:
£l l2£2 ~-l)
b2 (x2 - xx)
or slope of regression equation during V00 mode x100(%)
slope of regression equation during VAT mode
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(G). Heart Rate/QT Interval Relation -
Inter-Patient and Intra-Patient Variation:
(i) Exercise Heart Rate/QT Interval Relation in Patients
with Normal QRS Configuration and Atrio-Ventricular
Conduct ion_|_
Linear regression equations describing the heart rate/QT
interval relation was examined in Section C patients to
determine the extent to which this relation exhibited
patient variation.
(ii) Exercise Paced-Ventricular Rate /QT Interval
Relation in Patients with Atrial Synchronized Ventricular
Pacemakers - Inter-Patient Variation:
(a) QT interval variability was examined at a
paced-ventricular rate of 70 bpm at rest.
(b) Variability of paced-ventricular rate/QT interval
relation during exercise in VAT pacing mode was examined
in the 24 patients with atrial synchronized ventricular
pacemakers (Section F).
(c) Contribution of Heart Rate to Exercise-Induced
QT Interval Shortening A Within Patient Study of
Inter-Patientand Intra-Patient Variation;
In 11 of the 24 patients with atrial synchronized
ventricular pacemakers discussed in Section F, treadmill
exercise tests during both pacing modes (VOO and VAT) were
repeated after an interval of 8 to 12 weeks.
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Changes in the paced-ventricular rate/QT interval relation
with the passage of time were examined on a within-patient
basis by comparing the linear regression equations of the
two pairs of exercise tests in each subject.
(H). Effect of Acute Beta Adrenergic Receptor Blockade
on the Heart Rate/QT Interval Relation:
(i). Effect of Acute Beta Adrenergic Receptor Blockade
on the Paced-Ventricular Rate/QT Interval Relation in
Patients with Atrial Synchronized Ventricular Pacemakers:
In 3 patients with atrial synchronized ventricular
pacemakers treadmill exercise tests were performed during
fixed-rate, 70 bpm, and atrial synchronized ventricular
pacing modes, with at least an hour of rest in between
tests. The patients were re-exercised 2 hours after beta
adrenergic receptor blockade with an oral dose of 100 mg
oral atenolol. Each patient therefore had a total of 4
exercise tests.
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(I-i). Paced-Ventricular Rate/QT Interva1/Ventricular
Effective Refractory Period Relations;
Ventricular Effective Refractory Period;
Fourteen patients participated in the study. The patients
were those with complete heart block who were awaiting
implantation of a permanent pacing system and who had
temporary ventricular leads, or who were undergoing
electrophysiological studies. None of the patients was on
any medication which was likely to affect the QT interval
or ventricular effective refractory period.
Each subject underwent ventricular pacing at a randomly
selected rate for a period of two minutes, following which
the ventricular effective refractory period was measured
by the extrastimulus technique (Curry, 1975) using a
programmable stimulator (Devices) and 5 ms decrements, at
a pulse duration of 1.0 ms and at twice diastolic
thresholds. Ventricular effective refractory period was
defined as the longest coupling interval of ventricular
extrastimuli which did not result in ventricular
depolarization (Figure 3). The electrocardiogram was
simultaneously recorded at a paper speed of 50 or 100 mm
per second. The paced-ventricular rate/QT interval and
paced-ventricular rate/ventricular effective refractory
period relations were established in individual subjects,
by repeating the above exercise for as many paced-
ventricular rates as possible.
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(ii) Effect of Acute Beta Adrenergic Receptor Blockade
on the Heart Rate/QT Interval Relation During Exercise,
in Normal Subjects
The effects of acute beta adrenergic receptor blockade on
the heart rate/QT interval relation during exercise were
examined in 9 normal subjects, aged 28 to 40 years (8
males). Each subject underwent an identical treadmill
exercise test before and 2 hours after an oral dose of 100
mg atenolol.
(iii) . The Effect of Chronic Beta Adrenergic Receptor
Blockade on the Heart Rate/QT Interval Relation During
Exercise:
The effects of prolonged beta adrenergic receptor blockade
on the heart rate/QT interval relation were studied by
examining the exercise electrocardiograms of 22 patients
who were on a daily oral dose of 100 mg atenolol and had
been on this medication for more than 3 months (mean 5.5
months; range 3.5 to 10 months). Patients with
significant exercise-induced ischaemic ST/T wave changes
were excluded from the study.
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(ii) Effect of Amiodarone on the Paced-Ventricular
Rate/QT Interval/Effective Ventricular Refractory Period
Relations:
The effects of amiodarone on the QT interval and
ventricular refractory period was studied in 10 patients
who were being treated in the coronary care unit for a
variety of tachyarrythmias which had proven resistent to
conventional therapy. There were S males. The average
age of the patients was 63 years (range, 50 to 73 years).
Five drug half-lives separated previous medication and
institution of amiodarone therapy. Each patient was
treated with a 5 mg/kg intravenous amiodarone, given over
30 minutes, followed by a further 1000 mg intravenous drug
over 24 hours. This was followed by a once or twice daily
dose of 400 mg amiodarone for two weeks. Once every
twenty four hours, the patients were paced at a
ventricular rate of 120 beats per minute for a period of 2
minutes and the ventricular effective refractory period
















(iii) Effect of Sotalol on the Paced-Ventricular Rate/QT
Interval/Effective Ventricular Refractory Period
Relations:
Using the electrocardiographic and refractory period
measurements from 13 patients provided kindly by Dr. D.H.
Bennett, QT intervals and ventricular effective refractory
period changes were compared at a paced-ventricular rate
of 120 beats per minute, before and 10 to 20 minutes after
the completion of an infusion of sotalol hydrochloride,
1.5 mg per kg body weight, given over 5 minutes.
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CHAPTER III RESULTS
(A). Estimation of Error of QT Interval Measurements
- Intra-Observer Error:
In order to assess the error of QT interval measurements,
40 QT interval estimations were repeated by the author, 3
to 6 months after the original QT interval calculations to
determine the intra-observer error.
The QT intervals estimated on the first and second
occasions, X and Y respectively, are shown in Table II.
The within-subject variance for the two sets of QT
2
interval measurements 0 is given by the following
equations :>Fx2 + ^Y2 - £(X+Y)^ -r 40 = 37 .
2
Hence <3 equals 6.08 and the coefficient of intra-observer
error equals 6.08 x 100 = 1.56%
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The data was based on exercise data where the paper speed
was 25 mm per second and therefore most likely to provide
the largest differences in calculations of QT interval
performed on the two occasions. The intra-observer error
however was satisfactorily small. It is probably even
smaller at paper speeds of 50 or 100 mm per second, which
was the method most commonly adopted in the thesis, and
where QT intervals were measured at rest at a single
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heart rate, for example during pacing.
Possible sources of error include indistict terminal
portion of the QT interval, presence of prominant T waves
and unstable baseline, which were all avoided as far as
possible.
(B). Determination of the Regression Equation which
Best Describes the Heart Rate/QT Interval Relation -
Curve Fitting:
QT intervals measured at various heart rates recorded
during treadmill exercise tests in 14 patients are shown
in Table III. The data was subjected to linear,
exponential, logarithmic and power curve regression
analysis to determine which equation best described the
heart rate/QT interval relation. Table IV compares their
respective coefficients of correlation.
Exponential and linear regression equations provided the
most frequent best curve fit (5 patients each, Table IV).
The differences were small but exponential regression
equations provided the highest mean coefficient of
correlation. Coefficients of correlation for exponential
equations were significantly higher than those for
logarithmic regression equations (p<0.05). There were no
significant differences between the remaining comparisons.
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It was therefore decided to subsequently use linear
regression equations to describe the heart rate/QT
interval relation, as this facilated comparison of data.
(C-i) QT Interval Values and Heart Rate/QT Interval
Relation Determined at Rest:
Heart rate/QT interval relation was examined after
prolonged rest in 10 subjects in an attempt to reduce the
effect of autonomic nervous system activity on the
duration of the QT interval and thus define a narrow range
of 'normal' QT intervals. A total of 122 electro¬
cardiographic recordings were made and the measured QT
intervals at the various heart rates are shown in
Table V.
The mean (+ 1 S.D.) heart rate and QT interval recorded in
each subject is shown in Table VI which shows that,
despite prolonged bed rest, there was a significant range
of heart rates and that the QT interval varied from 358 +
12 ms to 398 + 11 ms (mean + 1 S.D.) in individual
subjects.
A reasonable negative correlation was found between the
resting heart rates and QT intervals, which varied in each
subject.
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The linear regression equation describing the heart
rate/QT interval relation in individual subjects was as
fol1ows:
Subject QT = a - b X Heart Rate r
1 . 535 - 2.12 X Heart Rate -0.86
2. 552 - 2.00 X Heart Rate -0. 62
3. 526 - 2.04 X Heart Rate -0.66
4. 493 - 1.69 X Heart Rate 00O1
5 . 521 - 2.04 X Heart Rate 1 o o
6. 540 - 2.53 X Heart Rate 1 o
7. 495 - 1.86 X Heart Rate LDCOO1
8. 515 - 1.97 X Heart Rate 1 o o
9. 538 - 2.25 X Heart Rate -0 . 75
10. 534 001—11 X Heart Rate ro00o1
Bazett's correction formula provides the following wide
range of QT values for a heart rate of 60 beats per
minute: 419, 414, 416, 403, 407, 392, 391, 406, 411,
427 ms. From the regression equations the following QT
interval values may be derived for the same heart rate:
408, 432, 404, 392, 399, 388, 383, 397, 403 and 415 ms
(mean + 1 S.D. QT interval - 402 + 14 ms).
Hence, it was not possible by this method to eliminate
inter-subject and intra-subject variation.
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(C-ii) QT Interval and Heart Rate/QT Interval Relation
Examined During Sleep:
As heart rate and QT interval measurements during
prolonged bed rest may still have been associated with a
certain degree of anxiety which may have accounted for the
patient variability affecting the heart rate/QT interval
relation, electrocardiographic recordings were also made
on two occasions during sleep in 12 subjects.
The mean QT intervals and heart rates on the two occasions
are shown in Table VII.
Heart rates recorded during sleep were lower than the
resting heart rates reported in section C-i. However, the
QT intervals again differed significantly from patient to
patient; range 370 to 435 ms.
The correlation between heart rate and QT interval was
less good because of the small range of these values.
Linear regression equation provided the best curve fit and
the relation between heart rate and QT interval during
sleep for the group could be represented as follows:
QT (ms)= 516 - 1.75 xHeart Rate (bpm), r = 0.6073, p<0.01.
(The coefficient of correlation for the corresponding
exponential, logarithmic and power regression equations,
were 0.6136, 0.6044 and 0.6103, respectively).
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(D). Heart Rate/QT Interval Relation During Exercise:
Heart rate changes during exercise are mediated through
vagal (largely at the beginning) and sympathetic
(responsible for most of the changes at maximal exercise
test) nervous system activity. The corresponding QT
interval changes may be due to alterations in heart rate
and autonomic nervous system activity. The heart rate/QT
interval relation was examined during exercise in 14
patients to determine whether this differed from that
described at rest.
Table VIII shows the linear regression equations
describing the heart rate/QT interval relations during
treadmill exercise tests in individual subjects.
The results indicated the following:
(a) the exercise heart rate/QT interval relation was
subject to significant patient variation and
(b) despite a greater level of sympathetic activity, the
slope of the exercise linear regression equation for the
group (QT = 493 - 1.57 x heart rate) was less than the
resting or sleep regression equations. The heart rate/QT
interval relation therefore is linear at heart rates of 68
to 188 beats per minute during exercise, but if the data
includes a significant number of resting heart rate and QT
interval values (i.e. a combination of Tables III and V)
the heart rate/QT interval relation would be more
curvilinear.
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(E). The Heart Rate/QT Interval Relation at Rest
During Pacing:
(i) Atrial Pacing
Heart rate changes during rest and sleep are brought about
by fluctuations in autonomic nervous system activity and
are largely due to variations in vagal activity. QT
interval changes during pacing are more purely
rate-related.
The heart rate/QT interval relation was therefore examined
during atrial pacing at rest and compared with the heart
rate/QT interval relation obtained during exercise.
Linear regression equations describing the atrial rate/QT
interval relation at rest in 11 subjects are shown in
Table IX.
The slopes of the regression equations obtained at rest
during atrial pacing were significantly less (P<0.01) than
slopes of exercise regression equations (section D).
The overall relation between the paced-atrial rate and QT
interval was defined by the following regression
equation:
QT Interval (ms) = 465 - 0.98 x Atrial Rate (bpm).
The slope of this regression equation was also
significantly less (p<0.01) than the slope of the linear
regression equation describing the overall heart rate/QT
interval relation during exercise (section D).
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(ii) Comparison of Paced-Atrial Rate/QT Interval and
Paced-Ventricular Rate/QT Interval Relations Determined
at Rest:
Certain studies reported in the literature and undertaken
in this thesis involve studying the heart rate/QT interval
relation with ventricular pacing. This section defines
the paced-ventricular rate/QT interval relation at rest
and compares the heart rate/QT interval relation during
atrial pacing (normal QRS confuguration) and ventricular
pacing (broad QRS complexes) at rest in the same group of
11 subjects.
The paced-atrial and ventricular rate/QT interval
relations in individual subjects are compared in
Table IX.
There was no correlation between the slopes of the paired
linear regression equations describing the atrial and
ventricular/QT interval relations, probably partly because
of the small range of available slopes. There was no
significant difference (p>0.1) between the slopes of the
paced-atrial rate/QT interval and paced-ventricular
rate/QT interval regression equations.
The overall paced-ventricular rate/QT interval relation
was described by the following linear regression equation:
QT Interval (ms) = 537 - 0.99 x Ventricular Rate (bpm).
For example, the QT interval at an atrial pacing rate of
60 and 150 beats per minute equals 374 ms and 284 ms i.e.
a QT interval shortening of 86 ms and the QT intervals for
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identical pacing rates equal 477 ms and 388 ms or a
similar QT interval of 89 ms.
(iii) The Rate Of Adaptation of the QT Interval to
Changes in Heart Rate:
Heart rate changes constantly during exercise and the
heart rate and QT interval measurements are therefore
random. During pacing, however, QT interval measurements
are made at a constant heart rate after a specified length
of time. It was therefore decided to determine whether
the QT interval was subject to hystereis in relation to
pacing rate. Six patients underwent right ventricular
pacing for 10 minutes at a rate of 110 beats per minute.
The pacing rate was then suddenly reduced to 50 beats per
minute and the duration of the QT interval for each
complex thereafter was measured to determine the time it
took, if any, for the QT interval to reach a constant
value in response to the heart rate.
The results in each subject are illustrated in Figure 4.
The missing data was due to collision of p waves with the
terminal portion of the T wave. QT interval adaptation to
the new lower pacing rate was most rapid in the first 20
seconds, with most of the adaptation completed by 45
seconds.
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Figure 4. Consecutive QT intervals determined following
a change in paced-ventricular rate from 110 to 50 beats
per minute.
65
In each patient, however, exercise-induced QT interval
changes during V00 pacing mode were less than the QT
interval changes which occurred during VAT pacing for a
given increase in atrial rate (Table XI). This is also
shown by comparing the slopes of the linear regression
equations describing the overall atrial rate/QT interval
and paced-ventricular rate/QT interval relations during
V00 and VAT pacing modes, respectively;
Fixed-Rate Ventricular Pacing Mode:
QT Interval (ms)= 531 - 0.96x Atrial Rate (bpm) and
Atrial Synchronized Ventricular Pacing Mode:
QT Interval (ms)= 563 - 1.75x Paced-Ventricular Rate
(bpm).
Comparison of the slopes of these two regression equations
further indicates that only 45% of the QT interval
shortening recorded during exercise may be attributed to
heart rate.
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(F). Contribution of Heart Rate to QT Interval
Shortening During Exercise
Patients with implanted atrial synchronized ventricular
pacing systems provided the opportunity to quantify the
contribution of heart rate to QT interval shortening
during exercise on a within patient basis. With the
pacemaker programmed externally to fixed-rate, 70 beats
per minute ventricular pacing mode (VOO), any QT interval
shortening would occur as a result of factors other than
heart rate, whilst during atrial synchronized ventricular
pacing mode (VAT), heart rate and factors unrelated to
heart rate, act on the QT interval.
QT intervals measured in each of the 24 patients with VAT
pacemakers at various atrial rates during VOO pacing mode
and ventricular pacing rates during VAT pacing modes with
exercise are shown in Table X.
The linear regression equations describing the atrial
rate/QT interval (VOO mode) and paced-ventricular rate/QT
interval (VAT mode) relations during exercise in each
subject are compared in Table XI.
The QT interval did shorten during exercise in the absence
of a chronotropic response during VOO pacing mode. The QT
interval changes during fixed-rate ventricular pacing
moreover correlated well with the independent atrial rate,
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(_G)_ Heart Rate/QT interval Relation -
Inter-Patient And Intra-Patient Variation
Examination of the data of several studies indicates that
the heart rate/QT interval relation is subject to
significant patient variation:
(i) Exercise Heart Rate/QT Interval Relations in
Patients with Normal Electrocardiograms;
Comparison of the linear regression equations describing
the relation between heart rate and the QT interval during
exercise in normal subjects, discussed in section B and
detailed in Table IV, shows that the heart rate/QT
interval relation varied sigificantly from one subject to
another. For example, the regression equations suggest
that at a heart rate of 60 beats per minute, the QT
interval would vary between 360 ms to 421 ms, or a
difference of 61 ms. Similarly, at a heart rate of 150
beats per minute, the QT interval would vary from 209 ms
to 328 ms, an even larger variation of 119 ms (Figure 5).(ii) Evidence from Studies Involving Patients with
Implanted Atrial Synchronized Ventricular Pacing Systems:
(i) Variation in the Duration of the QT Interval,
Measured During V00 Pacing Mode Prior to Exercise Tests:
The QT interval after 30 minutes of rest measured during
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fixed-rate ventricular pacing at 70 beats per minute in
the 24 patients with implanted VAT pacing systems prior to
the onset of exercise tests showed that the QT interval
varied from 395 ms to 510 ms (Table X).(ii) The Paced-Ventricular Rate/QT Interval Relation:
The heart rate/QT interval relation during VAT pacing mode
as shown in Figure 5 also varied significantly from
patient to patient. For example, the QT interval is
estimated to vary from 400 ms to 528 ms, at a ventricular
pacing rate of 60 beats per minute and 264 ms to 384 ms at
a ventricular pacing rate of 150 beats per minute.
Similarly, the contraction in the duration of the QT
interval, associated with an increase in pacing rate from
70 to 150 beats per minute, varied from 105 ms to 236 ms
(Figure 5).(iii) Contribution of Heart Rate to Exercise-Induced QT
Interval Shortening:
(a ) Inter-Patient Variation:
The VAT pacemaker model provides also information as to
the extent to which the contribution of heart rate to QT
interval shortening during exercise is subject to patient
variation. By comparing the slopes of paired regression
equations, derived during exercise in VOO and VAT pacing
modes, the contribution of heart rate to QT interval
changes was derived for individual patients and as shown
68
in Table XI varied between 16% to 75%.
(b) Inter-Patient and Intra-Patient Variation in
Patients Who Had Two Sets of Exercise Tests:
The linear regression equations in the 11 subjects who had
two sets of exercise tests during V00 and VAT pacing modes
are compared in Table XII. In this subgroup, the minimum
and maximum contributions of 'factors which were unrelated
to heart rate' to exercise-induced QT interval shortening
are shown for each patient and for the group in Figure 7.
The contribution of heart rate to QT interval changes
varied from 20% to 75% in different subjects and from 23%
to 75%, in the same patient from one occasion to another
(patient 5, Table XII).
Figure 7. Minimum and maximum contributions made
by factors other than heart rate to QT interval
shortening during exercise tests performed on two
separate occasions.
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H. The Effect of Beta Adrenergic Receptor Blockade on
the Heart Rate/QT Interval Relation During Exercise
(i) Effect of Acute Beta Adrenergic Receptor Blockade
on the Atrial Rate/QT Interval and Paced-Ventricular
Rate/QT Interval Relations in Patients with Atrial
Synchronized Ventricular Pacing Systems:
The correlation between atrial rate and QT interval
shortening during fixed-rate ventricular pacing mode, as
described in section F, suggested that autonomic nervous
system activity plays an important part in determining QT
interval changes during exercise. This finding was
investigated further by examining the atrial rate/QT
interval and paced-ventricular rate/QT interval relations
during V00 and VAT pacing modes, respectively, in 3
patients, before and 2 hours after an oral dose of a 100
mg atenolol. Linear regression equation describing (A)
the paced-ventricular rate/QT interval before beta
adrenergic receptor blockade during VAT pacing mode,
(effect of heart rate and autonomic nervous system
activity), (B) atrial rate/QT interval relation during VOO
pacing mode before beta adrenergic receptor blockade
(effect of autonomic nervous system activity), (C) the
paced-ventricular rate/QT interval relation during VAT
pacing mode after atenolol therapy (effect of heart rate
and parasympathetic nervous system activity) and (D)
atrial rate/QT interval relation during VOO pacing mode
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after atenolol therapy (effect of parasympathetic nervous
system activity alone) in the 3 subjects are illustrated
in Figures 8, 9 and 10 and further compared in Table
XIII.
The results show that although the relations between the
various regression equations varied from one subject to
another, in all 3 patients, QT interval changes during VOO
pacing mode were less than those during VAT pacing mode
[QT(A) compared with QT(B)]. Secondly, acute beta
adrenergic receptor blockade reduced the slopes of the
regression equations during VAT and VOO pacing modes
[QT(C) compared with QT(A) and QT(D) compared with QT(B)].
Thirdly, sympathetic nervous system appeared to account
for most of the QT interval shortening during exercise in
VOO pacing mode as shown by the effect of atenolol on the
atrial rate/QT interval relation in this pacing mode
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Figure 8. Patient A; Atrial/QT interval and heart
rate/QT interval relations during exercise tests,
performed during fixed-rate (VOO) and atrial synchronized
(VAT) ventricular pacing modes, respectively, before and
two hours after an oral dose of a 100 mg atenolol.
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Figure 9. Patient B; Atrial/QT interval and heart
rate/QT interval relations during exercise tests,
performed during fixed-rate (V00) and atrial synchronized
(VAT) ventricular pacing modes, respectively, before and
two hours after an oral dose of a 100 mg atenolol.
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Figure 10. Patient C; Atrial/QT interval and heart
rate/QT interval relations during exercise tests,
performed during fixed-rate (VOO) and atrial synchronized
(VAT) ventricular pacing modes, respectively, before and
two hours after an oral dose of a 100 mg atenolol.
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Figure 11a. Regression lines describing heart
rate/QT interval relations in the 9 normal subjects
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Figure lib. Regression lines describing heart
rate/QT interval relations in the 9 normal subjects
during exercise, two hours after an oral dose of a
100 mg atenolol.
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(ii ) The Effect of Acute Beta Adrenergic Receptor
Blockade on the Heart Rate/QT Interval Relation During
Exercise in Normal Subjects:
The effect of acute beta adrenergic receptor blockade on
the heart rate/QT interval relation during exercise was
further investigated in a group of 9 normal volunteers.
QT interval values determined at various heart rates
recorded during exercise, before and after an oral dose of
a 100 mg atenolol are shown in Table XIV and the
corresponding linear regression equations describing the
heart rate/QT interval relations in individual subjects
are compared in Table XV.
The slopes of the regression equation after acute beta
blockade were reduced in every subject, (for the group,
p<0.01). The finding is further illustrated by comparing
the slopes of the regression equations describing the
heart rate/QT interval relation for the group, before and
after atenolol; Pre-Beta Adrenergic Receptor Blockade:
QT Interval (ms) = 493 - 1.58 x Heart Rate (bpm) and
Post-Beta adrenergic Receptor Blockade:
QT Interval (ms) = 481 - 1.165 x Heart Rate (bpm).
Acute beta adrenergic receptor blockade resulted in QT
interval prologation which was more evident at higher
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compared with QT interval values obtained in subjects who
were not on any medication (A - section B and A ' - section
H-ii ) .
Similarly, the slope of the linear regression equation
describing the relation between heart rate and QT interval
for the group, [QT Interval (ms) = 520 - 1.71 x Heart Rate
(bpm)], in patients on chronic beta adrenergic receptor
blockade was not significantly different from control
subjects A and A', as illustrated in Figure 12.
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(iv) Comparison of Resting and Exercise
Heart Rate/QT Interval Relations and the Effect of
Acute and Chronic Beta Adrenergic Receptor Blockade
on the Heart Rate/QT Interval and Heart Rate/QTc
Interval Relations:
(a ) Heart_ Rate/QT Interval ;
The slopes of the regression equations expressing the
paced-atrial rate/QT interval relation at rest (section
E-i, Table IX), were significantly (p<0.002) less than the
slopes of the linear regression equations describing the
heart rate/QT interval relation during exercise
(section B, Table IV).
By comparison, there was no significant difference (p>0.1)
between the slopes of the paced-atrial rate/QT interval
regression equations at rest and the slopes of the
exercise heart rate/QT interval regression equations after
acute beta adrenergic receptor blockade (as shown in
Figure 12 and by the comparison of Table IX with
Table XV).
(b) QTc Interval:
QTc interval which is based on Bazett 's formula and which
corrects the measured QT interval for an arbitary heart
rate of 60 beats per minute should remain constant under
all circumstances - at rest, during exercise and after
beta adrenergic receptor blockade, if heart rate alone
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accounts for differences in the duration of the QT
interval. This was not observed to be the case.
QTc, during exercise in the controls A and A', increased
progressively to reach a maximum at a heart rate of 100 to
110 beats per minute (Figures 13a and 14), and thereafter,
with increasing heart rates, QTc became progressively
smal1.
By comparison, QTc continued to increase beyond heart
rates of 100 beats per minute after acute beta adrenergic
receptor blockade, as shown in Figure 13b. Hence acute
beta adrenergic receptor blockade significantly increased
QTc at a heart rate of 120 beats per minute (Figure 14).
In contrast to these findings, QTc interval relation in
patients on long term atenolol therapy did not continue to
increase beyond heart rates of 110 beats per minute and
the heart rate/QTc interval relation behaved similarly to
that in patients who were not on any medication, such as
controls A and A' (Figure 14).
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HEART RATE (beats per minute)
Figure 12. Comparison of linear regression lines,
describing the heart rate/QT interval relations during
exercise (A) in 14 normal subjects, (A') in 9 subjects
before and (B) two hours after an oral dose of a 100 mg
atenolol, and (C) in 16 patients who had taken a 100 mg
atenolol daily for more than three months and (D) at
rest during atrial pacing in 11 patients.
• ••••••••••
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Figure 13a. QTc changes with increasing heart
rates during exercise, in nine subjects, before
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Figure 13b. QTc changes with increasing heart
rates during exercise in nine subjects, two hours
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Figure 14. Comparison of mean QTc changes with
increasing heart rates during exercise in (A) 14
normal subjects, (A') 9 normal subjects before and
(B) two hours after an oral dose of 100 mg atenolol,
(C) 16 patients who had taken a 100 mg atenolol
daily for more than three months and (D) during
atrial pacing at rest.
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I-i Paced-Ventricular Rate/QT Interval/Ventricular
Effective Refractory Period Relations:
Changes in the duration of ventricular effective
refractory period (VERP) reflect local events, whilst
corresponding changes in the QT interval indicate more
global myocardial events. The duration of both intervals
is affected by heart rate and it has been the practice in
the literature to report on the class III activity of a
drug based on measurements made at a single pacing rate.
This section explores the relation between these variables
over a range of paced-ventricular rates.
QT interval and VERP values obtained at various
paced-ventricular rates in 10 patients are shown in
Table XVIII.
In individual subjects, a negative correlation existed
between the paced-ventricular rate and the QT interval,
and between paced-ventricular rate and VERP as shown in
Table XIX and Figure 15. As would therefore be expected,
a positive correlation also existed between VERP and the
QT interval (Table XIX and Figure 16). The paced-
ventricular rate/QT interval, paced-ventricular rate/VERP
and VERP/QT interval relations differed significantly from
patient to patient (Table XIX).
In 13/14 patients, the QT interval contracted more than
VERP for a given increase in the ventricular pacing rate,
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Figure 15. Linear regression lines describing the
paced-ventricular rate/QT interval (solid lines)
and paced ventricular rate/VERP (broken lines), in












VERP = 0.64QT - 12
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re 16. Ventricular effective refractory period
P)/QT interval relation.
77
equations shown in Table XIX.
The overall relations between heart rate and QT interval
and VERP and VERP and QT interval were expressed by the
following regression equations; QT Interval (ms) 521 -
1.01 x Paced-ventricular Rate (bpm), r = -0.90, VERP (ms)
= 323 - 0.65 x Paced-Ventricular Rate (bpm), r = -0.79 and
VERP (ms) = 0.64 x QT (ms) - 12.
These regression equations suggest that for a QT interval
shortening of 100 ms at rest, VERP reduced by 52 ms.
There was no change in the ratio VERP.-QT interval between
ventricular paced rates of 60 to 120 beats per minute as
shown in Table XX.
The Effect of Amiodarone on the Paced-Ventricular
Rate/VERP/QT Interval Relations:
Antiarrhythmic drugs with class III activity such as
amiodarone may prolong both the QT interval and VERP.
There may however be quantitative difference between them
in terms of their effect on the heart rate/VERP/QT
interval relations.
Pre-treatment, maximal post-treatment, VERP and QT
interval values in 10 patients are shown in Table XXI.
Amiodarone significantly increased the duration of the QT
interval from 420 + 34 ms to 481 + 55 ms and VERP from 250
+ 23 ms to 323 + 62 ms, (mean + 1 S.D.), at paced-
ventricular rate of 120 beats per minute.
In contrast to the effect of heart rate, VERP changes with
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amiodarone were greater than the corresponding changes in
QT interval in half of the patients.
Consequently, the ratio of changes in the duration of VERP
to changes in the duration of the QT interval was equal to
1.2 (Table XX).
This is also reflected in the finding that the ratio of
VERP to QT interval increased from 250 ms/420 ms or 0.595,
pre-treatment, to 323 ms/481 ms or 0.672 with amiodarone
therapy.
(I-iii) The Effect of Sotalol on the Paced-Ventricular
Rate/VERP/QT Interval Relations;
The effect of sotalol, a beta blocker with class III
effect, on the heart rate/VERP/QT interval relations is
compared with the effect of amiodarone on the same
relations.
QT interval and VERP values measured at a ventricular
pacing rate of 120 beats per minute are detailed in
Tables XXIIa and XXIIb respectively.
At the same ventricular pacing rate, sotalol caused a
smaller increase in the duration of the QT interval VERP.
The QT interval increased from 398 + 29 ms to 427 + 29 ms
(mean + 1 S.D.) or by 29 ms and VERP increased from 214 +
13 ms to 242 + 22 ms (mean + 1 S.D.) or by 27 ms.
As the QT interval and VERP were prolonged almost to the
same extent a small but significant increase occurred in
the ratio of VERP to QT interval, as shown in Table XX.
Table II. Intra-■observer error: QT interval values
estimated on two separate occasions (X and Y).
QT Interval Estimate (ms)
No. 1st (X) 2nd (Y) No. 1st(X) 2nd (Y)
1. 405 415 2. 420 420
3. 425 420 4 . 382 385
5. 415 410 6 . 362 360
7. 350 352 8 . 332 330
9. 330 335 10. 350 340
11. 336 345 12. 340 350
13. 340 345 14 . 412 415
15. 412 420 16. 415 422
17. 415 420 18 . 425 426
19. 420 422 20 . 450 450
21. 455 450 22 . 445 440
23. 380 390 24. 420 422
25. 390 388 26 . 396 395
27. 380 395 28 . 380 395
29. 390 390 30. 345 345
31. 350 350 32. 332 335
33. 335 330 34 . 365 365
35 . 378 376 36. 485 395
37. 410 403 38 . 402 400





















































































































































































































































































































































































































































































































































































Table V. QT intervals determined after prolonged
bed rest at various heart rates.
Heart Rate QT Interval Heart Rate QT Interval
(bpm) (ms) (bpm) (ms )
72 376 C. 64 402
66 376 88 347
78 369 73 377
81 368 67 388
78 379 72 369
77 367 85 364
87 345 74 351
56 428 79 364
62 407 74 354
























Heart Rate QT Interval Heart Rate QT Interval
(bpm) (ms ) (bpm) (ms )
65 393 74 367
63 397 69 371
70 378 70 376
75 357 72 365
78 366 69 388
66 375 68 374
64 389 65 382
66 386 70 390
69 369 70 376
65 400 77 376
59 402 65 389
71 374
71 355 76 355
78 340 72 360
76 345 71 360
69 365 70 345
73 356 69 360
77 360 78 340
70 370 68 375
65 380 67 375
71 370
Table V continued:
Heart Rate QT Interval Heart Rate QT Interval
(bpm) (ms ) (bpm) (ms )
58 403 H. 57 401
62 385 58 403
66 353 66 391
72 356 67 385
73 363 69 382
80 345 76 352
74 363 80 363
78 362 70 370
80 355 71 371





















Table VI. Mean + 1 S.D. heart rate and QT intervals
measured in 10 subjects during prolonged bed rest.
Subject Heart Rate (bpm) QT Interval (ms)
1. 7 3+10 380+22
2. 7 3+9 376+22
3. 7 4 + 10 375+24
4. 6 9 + 6 376+12
5. 6 8 + 6 382+14
6. 72+4 358+12
7. 7 0 + 8 362+19
8. 6 9 + 7 379+16
9. 6 9 + 8 383+21
10. 6 9 + 6 398+11
All patients 71±2 377±11
Table VII. Mean QT intervals and heart rates
recorded on the two occasions during sleep in
12 subjects.




















10 . 58 400
62 398





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table XVI. QT intervals determined at various heart
rates during exercise, in patients who had taken a
100 mg atenolol daily for more than three months.
Subject Heart Rate QT Subject Heart Rate QT
51 435 2. 44 490
54 440 57 475
57 435 56 460
88 365 70 440
75 385 76 420
5 412 82 430
5 415
50 400 4 . 83 355
55 405 97 350
58 400 107 345
60 400 125 300
64 388 128 300
83 368 130 286
83 365 136 280
91 354 142 270
100 355
91 345
54 430 6. 50 400
62 420 65 400
111 390 81 380
88 365 86 365
94 360 92 345
88 375 105 340
75 386 109 328
67 380 122 318
64 405 125 318




Subject Heart Rate QT Subject Heart Rate QT
52 420 8. 53 405
78 400 56 390
94 360 81 375
105 320 81 365
74 370 88 350
65 390 97 350





60 440 10. 61 410
71 400 97 345
86 385 70 380
94 355 75 365
103 325 103 335

















Subject Heart Rate QT Subject Heart Rate QT
13. 59 425 14 . 54 440
61 410 54 435
77 400 56 430
84 375 65 410
100 380 68 400




15. 54 440 16 . 75 378
54 435 59 430
56 430 60 420
65 410 77 360
68 400 73 370
80 385 83 392
88 365 86 360
83 387 60 410
79 400 58 410
Units: Heart rate (bpm) and QT interval (ms) .
Table XVII. Linear Regression equations describing the
heart rate/QT interval relation during exercise in
individual patients who had taken a 100 mg atenolol
daily for more than three months.
Regression Equation
Patient QT(ms) = a - b x :Heart :Rate (bpm) r
1. 528 - 1.87 X Heart Rate 0.95
2 . 471 - 1.26 X Heart Rate 0.97
3. 568 - 1.81 X Heart Rate 0 .94
4 . 500 - 1.59 X Heart Rate 0.97
5 . 461 - 0.88 X Heart Rate 0.98
6. 592 - 1 .39 X Heart Rate 0.95
7 . 496 - 1.56 X Heart Rate 0.97
8. 480 - 1 . 39 X Heart Rate 0.97
9. 586 - 2.48 X Heart Rate 0.96
10. 472 - 2.04 X Heart Rate 0. 95
i—1i—1 475 - 1.40 X Heart Rate 0.94
12. 534 - 1 . 84 X Heart Rate 0.98
13. 534 - 2.02 X Heart Rate 0.97
14. 585 - 2.47 X Heart Rate 0.95
15. 524 - 1. 82 X Heart Rate 0.97
16. 510 - 1.42 X Heart Rate 0.98
Table XVIII. QT intervals and ventricular effective
refractory periods (VERP), measured at various
paced-ventricular rates (VR) in subjects who were not
on any medication.
Subject VR QT VERP Subject VR QT VERP
1. 55 520 2 . 77 475 273
60 510 308 84 435 267
71 498 305 97 425 257
86 485 303 109 400 236
100 465 292 115 386 231
115 450 281 130 375 219
143 425 259 143 355 214
150 430 249
3. 80 395 238 4 . 69 415
86 390 230 83 405 227
92 395 97 415 223
94 390 233 120 398 213
107 375 135 380 215
115 370 231 150 370 207





5 . 46 515 334 6 . 144 362 231
60 505 335 76 425
75 495 337 97 405
84 470 336 107 405
97 440 325 129 370
107 435 312 150 350 230
118 405 303 71 430 260
130 400 295 94 412 248
146 390 281 110 395 245
125 380 240
7. 75 460 260
85 435 260 8. 120 400 230
100 420 240 70 450 260
111 410 230 75 450 280
120 400 230 88 440 240
130 400 220 102 420 240
143 380 220 114 405 240
154 375 118 390




VR QT VERP VR QT VERP
82 382 280 10. 71 465
91 415 263 98 450 250
98 375 109 440 230
109 370 120 430 230
113 365 242 133 415 220
59 445 309 146 390 220
130 345 225 162 360 205
150 325 217 86 455 265
150 340
54 430 11. 39 500
54 425 305 40 485 320
71 475 295
81 400 277 81 470 287
83 420 84 460
94 405 100 450 267
103 400 113 450 261
110 380 120 410 251
115 390 262 146 387 229
125 375 158 370 229
133 360 242 30 510 320
136 355
143 350 238 13. 98 455 254
77 440 281 109 450 246
79 428 118 440 236
128 430 226
103 408 150 420 216







































































































































































































































































































































































































































































































































































































CHAPTER IV CONCLUSIONS AND DISCUSSION OF THE
FIRST PART OF THE THESIS
The duration of the QT interval may be affected by heart
rate or by autonomic nervous system activity. QT intervals
were measured after prolonged bed rest and during sleep to
reduce the level of sympathetic nervous system activity.
Despite this, it was not possible to define a 'normal
resting QT interval because of significant patient
variation. The QT interval varied between 358 + 12 ms and
398 + 11 ms, (mean +1 S.D.), at rest. The emphasis in the
remaining part of the thesis has therefore been to describe
QT interval changes over a range of heart rates rather than
to determine whether isolated QT interval estimations were
normal or otherwise.
Within the range of heart rates obtained during exercise,
the heart rate/QT interval relation is only slightly
curvilinear and although best described by an exponential
regression equation, the relation is more conveniently and
almost equally well expressed by a linear regression
equation. Linear regression equations have recently been
used by Rickards et al. (1979), Ackras et al. (1980) and
Rickards and Norman, (1981), to describe the heart rate/QT
interval relation.
The overall relation between heart rate and QT interval
changes during exercise was hence given by the following
80
linear regression equation;
QT interval (ms) = 493 - 1.57 x heart rate (bpm).
QT interval changes were less impressive where these were
brought about by an alteration in heart rate alone, such as
atrial pacing at rest. In comparison to the exercise heart
rate/QT interval relation, the heart rate/QT interval
relation during atrial pacing at rest in a group of 11
patients was described by the following linear regression
equation:
QT interval (ms) = 465 - 0.98 x paced-atrial rate (bpm).
Although intra-ventricular conduction is abnormal during
ventricular pacing and the QRS complexes are consequently
broad, almost identical QT interval changes occurred during
atrial and ventricular pacing at rest in the same group of
patients. For the group, the relation between ventricular
pacing rate and the QT interval was expressed by the
following regression equation;
QT interval (ms) = 537 - 0.99 xpaced-ventricular rate (bpm).
It therefore seemed valid to derive parallel information
from ventricularly-paced groups of patients.
An important observation is that the QT interval exhibited
hysteresis in relation to rate. This is particularly
relevant to the estimation of QT intervals during pacing at
rest. Although most of the changes in QT interval in
response to an alteration in pacing rate were complete by 45
seconds, it is recommended that at QT interval estimations
should be made only after at least two minutes of pacing
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at a certain heart rate. It suggests that comparisons of
rate/QT interval relations that are based on data which
include QT intervals measured at a fixed-heart rate after a
length of time and QT intervals obtained during rapid
changes in heart rate should be interpreted with caution.
It also has important implications for the QT responsive TX
pacemaker. As described in the second part of the thesis,
this pacing system senses the T wave of paced-ventricular
complexes and alters heart rate in relation to changes in
the duration of the interval between the stimulus and the T
wave (Stim.-T interval). This system can thus provide
measurements of this interval at rest at various programmed
heart rates and the relation between heart rate and this
interval at rest, derived in this way, has been used to
programme values which affect the quality of rate response.
The conclusion from this finding affecting the QT interval
implies that the Stim.-T interval measurements may also be
subject to hystereisis and thus Stim.-T interval
measurements performed at rest after a certain length of
time may not be directly relevant to the performance of the
pacemaker during exercise and therefore may not prove useful
in its programming.
The QT interval shortened with exercise during fixed-rate
ventricular pacing at 70 beats per minute. This finding,
together with the observation that QT interval changes
during pacing at rest were less than those occurring during
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exercise, indicated that factors other than heart rate
played a major part in determining the duration of the QT
interval.
Comparison of the slopes of the linear regression equations
describing the heart rate/QT interval relation during
prolonged bed rest with the less steep slopes obtained
during pacing at rest also suggested that where heart rate
changes were brought about by the autonomic nervous system
activity QT interval changes were more marked. That the
exercise-induced QT interval changes during fixed-rate
ventricular pacing correlated well with the independent
atrial rate was regarded as further evidence of the
involvement of the autonomic nervous system in the
determination of the changes in QT interval.
The atrial synchronized ventricular (VAT) pacemaker model
provided the opportunity to compare, on a within-patient
basis, QT interval shortening during fixed-rate ventricular
pacing with that occurring during VAT pacing mode which
permits theere the ventricular rate to alter in response to
changes in sinus rate. Two important findings emerged from
these studies. Firstly, by comparing the slopes of
regression equations describing the atrial rate/QT interval
relation during fixed-rate ventricular (only factors
unrelated to heart rate, namely autonomic nervous sytem
activity may act on the QT interval) and VAT (both heart
rate and autonomic nervous system activity may act on the
QT interval) pacing modes, factors unrelated to heart
rate were found to account for as much as 52 + 16% of
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the QT interval changes during exercise; QT interval (ms)
during VAT pacing was equal to: 564 - 1.75 x atrial rate
(bpm) and QT interval (ms) during fixed-rate ventricular
pacing at 70 beats per minute was equal to: 526 - 0.92 x
atrial rate (bpm). Secondly, by similarly comparing the
slopes of paired regression equations during exercise in
these two pacing modes it was concluded that the
contribution of heart rate to QT interval changes was
subject to significant patient variation. For example, the
contribution of heart rate to QT interval changes varied
from 20% to 75% from one patient to another and 23% to 75%
in the same subject from one occasion to the next.
Examination of the heart rate/QT interval relation during
exercise in subjects with normal electrocardiograms and also
studies involving atrial and ventricular pacing at rest,
confirmed that the heart rate/QT interval relation did
exhibit significant subject variation.
The reasons for this patient variation are unclear.
Ventricular myocardium may be affected by neurotransmitters
from activation of the left and right stellate sympathetic
nerves and vagus nerve, circulating catecholamines as well
as by the intrisic action of heart rate. In the varying
combinations and interactions of these factors may be found
part of the explanation for the observed patient variation.
Other explanations may include differences in the axis of
ventricular depolarization and sensitivity of the sinus node
to autonomic nervous system activity.
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Whatever the explanation, however, this inter-patient and
intra-patient variation which affects the heart rate/QT
interval relation has important implications for the use of
the QT interval as a biosensor to determine the pacing rate.
Programming of the QT-responsive pacemaker may have to be
carefully tailored to individual heart rate/QT interval
characteristics and, more seriously, the same change in the
duration of the QT interval may result in different pacing
rates at various times in the same patient. This aspect of
the performance of the rate responsive (TX) pacing system is
examined in part II of the thesis. It is as yet
undetermined how rapidly the heart rate/QT interval relation
varies in individual subjects and whether it is affected by
diurnal variation. These facts may be highly relevant to
the programming of this pacing system, if it is confirmed
that the heart rate/Stim.-T interval relation behaves
similarly to the heart rate/QT interval relation.
At rest, heart rate changes are largely mediated through
variations in vagal activity. During the initial stages of
an exercise test, withdrawal of vagal inhibition also makes
a significant contribution to the augmentation in sinus
rate. During the later stages of an exercise test,
sympathetic activity accounts for most of the increase in
heart rate. The fact that QT interval changes which
occurred during exercise with fixed-rate ventricular
pacing, in patients with implanted atrial synchronized
ventricular pacing systems, were virtually abolished by
atenolol, suggests that the sympathetic nervous system
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was primarily responsible for the autonomic contribution to
the exercise-induced QT interval shortening.
This observation was further examined by testing the effect
of atenolol on the heart rate/QT interval relation during
exercise in normal subjects. Acute beta adrenergic receptor
blockade reduced significantly the slope of the heart
rate/QT interval relation: pre-beta adrenergic receptor
blockade,
QT interval (ms) = 493 - 1.58 x heart rate (bpm), and
post-beta adrenergic receptor blockade,
QT interval (ms) = 481 - 1.16 x heart rate (bpm).
In contrast to this observation, the slopes of the heart
rate/QT regression equations describing the heart rate/QT
interval relation during exercise in patients on chronic
atenolol therapy were not significantly different from the
slopes of the linear regression equation in subjects who were
not on any medication,
QT interval (ms) = 520 - 1.71 x heart rate (bpm). Thus the
heart rate/QT interval relation in patients on beta
adrenergic receptor blocker therapy appears to change after
an unspecified interval of time and approximate the heart
rate/QT interval relation in subjects who are not on any
mediacation. This work supports the findings of Rickards and
Norman (1981) and Vaughan Williams (1980a, 1981 and 1982) and
suggests that whilst acute beta adrenergic blockade may
severely blunt or even abolish rate response in patients with
TX pacing system, adequate rate response may yet be achieved
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in patients on chronic atenolol therapy.
The data which accumulated in these studies permitted
examination of Bazett's QTc - measured QT interval,
corrected for heart rate, under different conditions. QTc
during exercise increased to maximal values around 100 to
110 beats per minute and thereafter decreased. Following
acute beta adrenergic blockade, QTc continued to prolong
beyond heart rates of 100 beats per minute. Chronic beta
adrenergic blockade increased the QTc values, but restored
the heart rate/QTc relation. The QTc was therefore not
deemed to be a useful correction factor, as it neither
provided for constant values during pacing at rest, nor
when heart rate was altered by exercise, nor in the
presence of acute beta adrenergic receptor blockade. It
is therefore recommended that the practice of reporting
observations based on QT intervals determined at a single
heart rate (such as the QTc - QT corrected for an arbitary
heart rate of 60 beats per minute) after a therapeutic
manoeouvre should be abandoned and instead efforts should
be made to characterize the effects on the heart rate/QT
interval relation, in individual subjects, over a wide a
range of heart rates.
Ventricular effective refractory period/QT interval
relation was examined as a possible means of relating
local events affecting ventricular depolarization to more
global myocardial changes. As with the QT interval, the
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ventricular effective refractory period (VERP) was found to
vary inversely with the paced-ventricular rate; VERP (ms) =
323 - 0.65 x paced-ventricular rate (bpm). However, the
effect of heart rate on VERP was less than on the QT
interval; QT interval (ms) = 521 - 1.01 x paced ventricular
rate (bpm).
As with the heart rate/QT interval relation, the heart
rate/VERP relation also varied significantly from patient to
patient.
Amiodarone and sotalol both increased substantially the QT
interval and VERP. With amiodarone, however, in half of the
patients VERP prolongation was greater than the
corresponding increase in the QT interval and thus the
VERP/QT interval ratio was altered, whilst with sotalol VERP
and QT interval prolongation occurred to the same extent.
PART TWO
ADVANTAGES OF PHYSIOLOGICAL PACING,
THE PACED-VENTRICULAR RATE/STIMULUS-T INTERVAL RELATION
AND THE PERFORMANCE OF THE
RATE RESPONSIVE (TX) PACING SYSTEM
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CHAPTER V INTRODUCTION:
Physiological or Adaptive Pacing:
Ventricular demand (VVI) is the most commonly used pacing
mode. Approximately ninety per cent of all pacing systems
implanted worldwide are of this type (Feruglio and
Steinback, 1983). They are relatively inexpensive,
reliable and effective in eliminating Stokes Adams attacks
due to bradycardia and most patients with very low heart
rate report an improvement in their symptoms and level of
activities.
Fixed-rate ventricular pacing at an arbitary rate of 70
beats per minute however may be associated with
deleterious haemodynamic effects and curtails the ability
of patients to improve their cardiac output to meet
increased physiological demand . Consequently, some
patients continue to complain of dizziness, fatigue and
dyspnoea.
A number of pacemakers are now available which are
designed to improve cardiac output and be more responsive
to the physiological needs of the patient. As no
pacemaker can be said to be truly 'physiological ' the term
'adaptive ' has also been adopted in this thesis to
describe these pacing systems.
These include:
(1) Pacing systems which only maintain the natural
sequence of cardiac chamber activation e.g. fixed-rate
89
atrial (AOO), atrial demand (AAI), atrial-triggered (AAT),
and atrio-ventricular sequential (DVI) pacemakers.
(2) Pacing systems which achieve both the natural
sequence of atrio-ventricular activation and permit a
chronotropic response to exercise e.g VAT, VDD (atrial
synchronized ventricular demand) and DDD (universal).
These pacemakers sense P waves via an atrial electrode
which triggers ventricular activation via a second
electrode after an interval of time which approximates to
the normal PR interval.
(3) Pacing systems which sense changes in a physiological
parameter and hence provide for a chronotropic response to
increased metabolic demands but without atrioventricular
synchrony.
Atrial electrical activity may still be used to indicate
physiological needs. The RS4/SRT pacemaker (Cardiac
Pacemakers Inc.) uses a single specially designed
transvenous tripolar lead to sense p waves in the right
atrium and pace the right ventricle: pairs of orthogonal
'floating' atrial electrodes are located at 10, 13 or 16
cm from the electrode tip, and are used for bipolar atrial
sensing but not atrial stimulation. The ventricular
pacing rate automatically varies between 63 and 115 beats
per minute as a function of change in atrial (p wave)
activity (Goldreyer et al., 1981). Significant
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improvements in patient exercise performance have been
described in the rate responsive mode (Goicolea de Oro et
al., 1985). The lead is technically more difficult to
implant because of its relative thickness and rate
response may be unreliable due to respiratory-induced
changes in the position of the sensor in the right atrium.
Approximately 50 per cent of all patients now undergoing
pacemaker implant may not be suitable for adaptive pacing
systems which rely on atrial electrical activity for their
input due to sinus node dysfunction or presence of atrial
arrhythmias (Rickards and Donaldson, 1983). There has
therefore been a search for independent indicators of
physiological demand.
The first such device was the pH triggered pacemaker
(Cammilli et al., 1977, 1979, 1982 and 1983). This
pacemaker utilized a pH sensing element which detected
changes in venous blood pH and allowed the ventricular
pacing rate to vary between 65 to 110 beats per minute.
Wirtzfeld et al., (1982, 1983 and 1984), described a rate
responsive pacing system based on measurement of mixed
venous O2 saturation. In 10 patients, they recorded
increases in cardiac output as a result of a rise in
pacing rate, in response to a fall in mixed venous O2
saturation. The application of this principle has been
limited by the time course of the O2 saturation changes.
Even under steady exercise conditions it takes 1 to 3
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minutes for O2 saturation to reach a steady value which is
proportional to the degree of exercise.
Rossi et al. (1984) have reported initial successes with a
pacing system (manufactured by Biotec) in which the pacing
rate is driven between upper and lower bounds by a
respiratory rate sensor. The respiratory rate is measured
by means of an auxiliary lead placed subcutaneously,
through the mid-sternum line, in the pectoral region on
the side opposite to the pulse generator. The respiratory
rate is detected by means of changes in electrical
impedence between the pulse generator and the auxiliary
lead. Among the problems reported with this system have
been dislocation of the auxiliary lead and inability in
some patients to obtain an optimum relation between the
respiratory rate and the pacing rate. This relation may
also be affected by respiratory disease. Despite these
problems the system has been successfully used to provide
AAI and rate responsive capability in patients with sinus
node dysfunction.
A pacemaker made by Medtronic (Humen et al., 1983 and
1984) has recently been described which is sensitive to
muscle noise. A good relation between muscle noise and
heart rate has been demonstrated and the system responds
well to moderate and vigorous exercise but not so well to
light exercise and not at all to emotional stress. The
main concern has been the triggering of the device by
environmental noise, such as travelling in a motor
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car (Ryden et al., 1984).
The TX-pacemaker, using a conventional lead, alters the
ventricular pacing rate in response to changes in the
QT-interval [or more accurately Stimulus artefact-to-T
wave interval (Rickards and Norman, 1981)].
Other biosensors which have also been considered include
central venous blood temperature (Griffin et al., 1983,
Laczkovics, 1984, Jolgran et al., 1984), right atrial
pressure (Cohen, 1984), and stroke volume (Neumann et al.,
1985 ) .
The increasing availability of different types of
pacemakers makes it important to establish if adaptive
pacing is of practical value to patients and if so which
aspect of adaptive pacing contributes most to improved
exercise performance.
This section addresses itself to these problems and
investigates the performance of the rate responsive TX
pacing system in the light of these considerations and in
particular, the observations made in the first part of




The aims of the study were to
A.
Investigate the advantages if any, conferred by
adaptive pacing as compared with fixed-rate
ventricular pacing at 70 beats per minute by:
(i) Recording changes in haemodynamic indices at the
time of pacemaker implantation, in patients
with heart block, as the cardiac rhythm changed
from second or third degree atrio-ventricular
block at a slow intrinsic ventricular rate
to ventricular pacing at 70 beats per minute, and
finally to atrial synchronized ventricular pacing
mode.
(ii) Comparing exercise performance during atrial
synchronized ventricular pacing with fixed-rate
ventricular pacing at a rate of 70 beats per
minute.
(iii) Determining whether the magnitude of changes in
haemodynamic indices recorded in the cardiac
laboratory could predict which patients would
benefit most from adaptive pacing.
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(iv) Establishing whether improvement in exercise
performance, if any, attributable to physiological
pacing, was maintained with the passage of time.
B.
Determine which aspect of atrial synchronized
ventricular pacing (maintenance of proper sequence
of cardiac chamber activation or rate response
without atrio-ventricular synchrony response)
contributed most to improved exercise performance.
Assess whether the findings of the above studies
are borne out by the results of studies in patients
with implanted rate responsive TX pacemaker.
The following investigations were to be undertaken
in patients with the TX pacing system:
(i) Compare exercise performance (a) during fixed-rate
ventricular pacing with atrial synchronized
ventricular pacing pre-pacemaker implantation and
(b) following pacemaker implantation, exercise
performance during rate responsive (TX) pacing mode
with fixed-rate ventricular pacing mode.
(ii) Determine (a) the ability of the TX pacing system
to sense T waves.
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(b) The effect of changes in pacing rate on T wave
amplitude.
(c) The effect of chronic T wave sensing changes,
if any, on the paced-rate/Stim.-T interval relation
and rate changes during exercise.
(iii) Ascertain the paced-ventricular rate/Stim.-T
interval relation and determine whether this
relation behaved similarly to the heart rate/QT
interval relation, in that it was subject to
significant patient variation.
(iv) Assess rate responses during exercise and by
Holter monitoring.
(v) Assess the reliability of the Stim.-T interval as a
biosensor and the effect of changes in programmable
indices - T wave sensitivity, slope and T wave
sensing window on rate changes during exercise.
(vi) Consider the best method for programming the
pacemaker.
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CHAPTER VI PATIENTS AND METHODS:
A. Comparison of Resting Haemodynamic Indices and
Exercise Performance During Atrial Synchronized and
Asynchronous Ventricular Pacing:
This study involved thirty-five patients who underwent
implantation with atrial synchronized ventricular (Cordis
208A or 308A) pacemakers for chronic symptomatic
atrioventricular block. The clinical details of the
patients are shown in Table XXIII. The two patients with
second degree atrioventricular block became rapidly
pacemaker dependent on institution of temporary
ventricular pacing. The criteria for exclusion were the
presence of sinus node disease, atrial flutter or
fibrillation, or inability to cope with exercise on the
treadmill due to impaired cerebral or locomotor function.
Informed consent was obtained in all patients.
Haemodynamic Measurements:
Resting haemodynamic measurements were performed in 28 out
of 35 patients.
Cardiac indices measured were: cardiac output and
pulmonary arterial pressure, using a thermodilution
catheter inserted percutaneously via the femoral vein and
systemic arterial pressures by percutaneous needle
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puncture of the femoral artery.
Recordings were made (where possible) during spontaneous
rhythm, asynchronous ventricular pacing at 70 beats per
minute (bpm) and atrial synchronized ventricular pacing.
Treadmi11 Exercise Tests and Assessment of
Exercise Performance
A total of 67 pairs of exercise tests (during VAT and V00
pacing modes) were performed in the 35 patients.
Exercise testing was performed on a motor driven treadmill
using the Bruce protocol (Bruce, 1971).
Pacing modes were chosen randomly with at least 30 minutes
interval between the tests. Each test was observed by two
physicians. One was responsible for the selection of the
pacing mode used first, for continuous electro¬
cardiographic monitoring and for measuring the systolic
blood pressure by sphygmomanometer during the last 15
seconds of each stage of the exercise protocol. He also
indicated that the exercise should be terminated only if a
potentially dangerous arrhythmia or hypotension occurred.
The second physician supervised the patient during
exercise and encouraged the patient to his/her
symptom-limited maximum effort. Neither this physician
nor the patient was aware of the pacing mode.
The following recordings were made: (a) symptoms resulting
in termination of exercise (angina, dyspnoea, exhaustion,
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leg fatigue or lightheadedness) (b) presence of
ventricular tachycardia (defined as 3 or more consecutive
ventricular complexes, occurring at a rate of greater than
120 beats per minute) and frequent ventricular premature
complexes (VPCs, defined as ventricular premature
complexes occuring at a frequency of 5 or more beats per
minute) (c) duration of exercise (d) systolic blood
pressure at the start of the exercise, at the end of each
stage of the exercise protocol and immediately after the
cessation of exercise (hypotension was defined as a fall
in systolic arterial pressure of 10 mmHg or more) and (e)
atrial rate at 3-minute intervals during exercise and
symptoms experienced during exercise.
Changes in haemodynamic indices recorded at the time of
pacemaker implantation were correlated with average
changes in exercise performance on changing from
fixed-rate, 70 bpm, ventricular pacing to atrial
synchronized ventricular pacing mode.
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Exercise performance was calculated either (a) as the
total distance walked on the treadmill (estimated from the
speed of the treadmill during each stage of the Bruce
protocol and the duration of the exercise test) or (b) as
the sum of work done during each stage of the Bruce
protocol.
C
It was assumed that work done on the treadmill on walking
an incline AC was equivalent to the sum of work done on
walking along AB against frictional force and along BC
against gravity.
Hence work done during each stage could be expressed as
fol1ows:
p x V x _3_ x (cosine 6 + sine 0 )
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where p= weight of patient; V= velocity of the treadmill
and 6 = angle of incline of the treadmill.
A change in work done during VAT pacing mode, was also
expressed as a percentage of the work done during VOO
pacing mode:
Total Work during VAT - Total work during VOO x 100 (%)
Work during VOO
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B. Atrial Synchronized Ventricular Pacing -
Contribution of Chronotropic Response to Improved
Exercise Performance:
Fourteen patients with atrial synchronized ventricular
pacemakers (Cordis model 308A), implanted for chronic
idiopathic atrioventricular block, were studied. The
clinical details of the patients are shown in Table XXIV.
Exercise testing on a motor driven treadmill, using the
Bruce protocol, was performed on all patients in 3
different pacing modes, selected in a random order
(Table XXV), (a) atrial synchronized ventricular (VAT)
pacing, (b) chest wall triggered ventricular (V-CWS-T)
pacing; and (c) fixed-rate ventricular (VOO) pacing at 70
beats per minute (Figure 17).
Chest Wall Stimulation Triggered Ventricular (V-CWS-T)
Pacing Mode:
A chronotropic response to exercise, similar to the
patient's atrial rate but without atrioventricular
synchrony was achieved using chest wall stimulation (CWS).
This was carried out using two electrodes connected to a
temporary pacing box, one (positive) applied directly to
the skin over the implanted pacemaker and another
(negative) to the third intercostal space, at the left
sternal edge. With the implanted pacemaker programmed to
VAT mode, chest wall stimuli rather than P waves triggered
E.C.G. recorded during three exercise tests
in a patient
1. Asynchronous Ventricular Pacing (V00):
2. Atrial Synchronised Ventricular Pacing (VAT):
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3. Pacemaker Programed to VAT Ucde but Driven
by Chest Wall Stimulation (V-CSS-T):
Figure 17. Exercise electrocardiograms during fixed-
ventricular rate (V00, 70 beats per minute),
atrial synchronised ventricular (VAT) and
chest wall stimulation triggered ventricular
(V-CWS-T) pacing modes.
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ventricular activity. The implanted pacemaker was thereby
driven externally at rates which were kept fractionally
above the independent atrial rate. The atrial rate was
measured at 20 second intervals from the
electrocardiogram. The Marquette CASE TM Computer
Assisted System for Exercise (Marquette Electronics,
Milwaukee, Wisconsin, U.S.A.) minimized baseline
electrocardiographic fluctuations and hence facilitated
measurement of atrial rate during exercise. Care was
taken to ensure atrioventricular asynchrony by
continuously monitoring the electrocardiogram, frequently
checking the electrocardiographic recordings and altering
the pacing rate accordingly.
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C. Studies on the TX Pacing Systems:
The TX pacing system was evaluated in 14 patients (9
patients had a TX pacemaker implanted at the Western
General Hospital and Royal infirmary, Edinburgh and 5
patients at Wythenshawe Hospital, Manchester). The
clinical details of the patients are shown in Table XXVI.
The indications for pacing were symptomatic, stable third
degree atrioventricular block in thirteen patients and
sinus bradycardia in one patient.
The patient with sinus bradycardia had satisfactory
atrio-ventricular conduction (A-V Wenchebach developed
with atrial pacing at 160 beats per minute) and had
previously received a permanent atrial demand pacing
system but had continued to suffer exertional syncope
despite normal pacemaker function. During treadmill
exercise tests he developed lightheadedness and ataxia
associated with hypotension, presumably on the basis of
exercise-induced vasodilatation and absence of an adequate
atrial rate response. Prior to TX pacemaker implantation,
he was fitted with a temporary ventricular pacing system
and re-exercised in two pacing modes: (i) ventricular
demand pacing at 80 bpm and (ii) where the pacing rate was
progressively increased in the first minute of exercise to
120 bpm. His exercise performance improved by 80 per cent
with the provision of rate increase and his blood pressure
rose during exercise (it fell when the heart rate was
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maintained at 80 beats per minute). He did have evidence
of intermittent ventriculo-atria1 conduction at rest.
This was however not associated with any untoward effects
and disappeared during exercise. The evidence therefore
suggested that he would benefit from a rate responsive
pacemaker
Comparison of Exercise Performance During TX, VAT and
Fixed Rate Ventricular Pacing Modes:
Temporary atrial and ventricular leads (Cordis) were
inserted in 8 patients pre-operatively and connected to a
Cordis 308A atrial synchronised generator adapted for
external use. The patients were exercised on the
treadmill using the Bruce protocol or a modified version,
in a double blind manner, during VAT and VOO (70 beats per
minute) modes, chosen randomly.
Two weeks after pacemaker implantation, the generator was
programmed to TX mode. Twelve of the 14 patients were
exercised, during rate responsive (TX) and ventricular
demand (VVI), 70 bpm, pacing modes, selected randomly.
The exercise protocol followed was identical in any pair
of exercise tests.
Stimulus-T Interval Measurements:
The Stim.-T interval was measured at rest and in the
supine position in increments or decrements of 10 beats
per minute, at paced-ventricular rates of between 40 bpm
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and 120 bpm on 75 occasions in 12 patients.
The Stim.-T measurements were made 2 minutes after
altering the paced-ventricular rate to permit the Stim.-T
interval to the adapt to the new heart rate.
The paced-ventricular rate/Stim.-T interval relation was
studied before and after exercise tests and at different
programmed T wave amplitudes.
The paced-ventricular rate/Stim.-T interval relation was
examined to determine the regression equation which
provided the best curve fit.
Comparison of Heart rate/QT Relation Derived from the
Surface Electrocardiogram with Heart Rate/Stim.-T
Interval Relation:
On 15 occasions the electrocardiogram was recorded at a
paper speed of 50 mm per second and at twice
magnification, immediately following measurement of the
Stim.-T interval at each paced-ventricular rate. In this
way, the paced-ventricular rate/Stim.-T interval relation,
derived from values displayed by the HP-85 computer, was
compared with the ventricular rate/QT interval relations
obtained from measurements made from the surface
electrocardiogram. Two paced-ventricular rate/QT interval
relations were studied based on (a) QT interval durations
calculated from the pacing artefact to the apex of the T
wave of the paced-ventricular complex, 'Stim.-T(Apex) ' and
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(b) from the pacing artefact to the terminal portion of
the QT interval of the ventricular complex, 'Stim.-T(SE)
Holter Monitoring:
Rate responses were also studied by 24 hour Holter
monitoring. Twenty-four hour Holter monitoring was
recorded on 18 occasions in 9 patients.
Description of the TX Pacing Systems Implanted:
The TX pacing systems which were implanted included the
TXl, TX2 and the newer Quintech model (3 patients).
(a) The TXl Pulse Generator:
The system uses a conventional unipolar pacing electrode
with a pacemaker capable of sensing the timing of the
evoked T wave that follows ventricular depolarization.
The pacemaker is sometimes referred to as QT-responsive
but should be more correctly called rate responsive,
Stimulus-T responsive or TX pacing system.
The TXl (Vitatron medical diagnostic pulse generator;
Vitatron Medical BV, The Netherlands) is lithium powered
and microprocessor based (RCA 1802) with a bit serial I/O
that permits full transcutaneous programmability through
radiofrequency coupling via a programmer head to an
external microcomputer (Hewlett-Packard HP-85) containing
the monitor programme in its operational memory. This
permits analysis and programming of all conventional and
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T wave tracking, pacing, and sensing variables.
Algorithms simulating normal physiological response alter
the paced rate in response to relative changes in the
interval between the stimulus and the T wave; a decrease
in this interval causes an increase in the rate and vice
versa. The sensivity or slope of the system to the
changes in the interval (from 0.5 to 5 bpm per ms) and the
slow exponential drift back to the basic rate (nulling)
(from 35 to 125 bpm per hour) are programmed
non-invasively 1 to 2 weeks after implantation and
tailored individually to produce steady increases in rate
(with a maximal rate of change set at 30 bpm per minute)
to reach a preset upper rate over 6 to 12 minutes and then
to gradually decrease to the basic pacing rate. In case
of malfunction of the T wave tracking mode the pacemaker
can revert to a standard ventricular inhibited
(programmable VVI) fixed-rate ventricular pacing mode.
(b) TX2 Pulse Generator:
In the course of the study, implanted TXl pacing systems
were externally programmed to TX2. In the TX2 pacemaker
the software is updated in such a way that the TX mode
will function in cases where the pacemaker is inhibited by
spontaneous rhythm. This 'tracking' property is of
particular value in patients who accelerate their
spontaneous rate and thereby switch off the rate
responsive mode. This is most likely to occur in patients
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with congenital atrio-ventricular block. Whenever the
pacemaker is inhibited in this way, it will gradually
decrease its escape interval (steps of 6.4 ms) until the
pacing rate is above the spontaneous rate. A pacing puis
will then be released and, if capture follows, the Stim.-
interval will be measured. On the basis of this measured
Stim.-T interval the pacemaker will increase the
paced-ventricular rate or slow down again and allow the
spontaneous rhythm to prevail. When employing this mode
it is appreciated that, in cases where spontaneous rhythm
is adequate, the electrocardiographic recording may show
mixture of fusion and pseudofusion complexes.
With this model, T wave amplitude is no longer displayed.
Instead the HP-85 computer will show the percentage of T
waves sensed at each programmed T wave sensitivity.
The Quintech TX Pulse Generator;
This latest TX model incorporates the tracking mechanism
as well as hardware change which involves the design of a
completely new filtering unit for T wave sensing, in the
expectation that this will overcome the problem of T wave
sensing which arises in some patients with TXl and TX2
models.
The pacemaker also has an antitachycardiac mode. There i
no available experience of this and its discussion is




In order to be sensed, T waves must (a) have an amplitude
greater than 0.5 mV, (b) possess a relatively fast
'down-sloping' (6 mV per ms) and (c) fall within the "T
wave sensing window" (Figure 18).
It has recently become possible to test how well the TX
pacing system senses the T waves of paced-ventricular
complexes at operation using an external device which
incorporates the Quintech TX sensing system. This device
indicates whether T wave sensing is good, indifferent, or
poor.
The quality of T wave sensing may be tested at rest using
the HP-85 computer. When the pacemaker has been
programmed to the TX mode, it is reassuring to observe
that the duration of the displayed Stim.-T interval varies
inversely with the programmed pacing rate. Additionally,
the TX2 and Quintech models indicate the number of T waves
sensed (expressed as a percentage of heart rate). This
value should ideally remain at 100 percent throughout the
range of heart rate. It falls during inadequate T wave
sensing and when ventricular pacing is inhibited by
spontaneous cardiac activity. A special 'beep' has been
incorporated that will be heard each time a T wave is
sensed.
Figure 18. Diagramatic representation of the evoked
response', Stim.-T interval and the T wave
sensing window.
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T wave Amplitude and Sensitivity:
T wave sensitivity is programmable from 0.5 mV through to
5.0 mV with the TX2 and Quintech models (0.5 mV to 3.0 mV
with TXl) in steps of 1 mV.
The effect of pacing rate on T wave amplitude was recorded
at rest in 9 patients with the TXl pacing system.
The effect of different T wave sensitivity settings on (a)
the paced-ventricular rate/Stim.-T interval relation at
rest was studied in 8 patients (recordings made at the
same clinic attendance) and (b) heart rate changes during
exercise in 3 patients.
T Wave Sensing Window:
After delivery of a pacing impulse the pacemaker is
refractory to all incoming signals during a blanking
period of 200 ms. Thereafter, a T wave sensing window,
which is programmable to 450 ms (calculated from the
pacing impulse), is set out. During this interval T waves
are sensed and timed (Figure 18). At the end of the T
wave sensing window, QRS sensing is enabled. The effect
of altering T wave sensing window on paced-ventricular
rate changes during exercise was studied on different days




The slope defines the sensitivity of the TX pacemaker to
changes in the Stim.-T interval. It is programmable from
0.5 to 2.7 beats per minute per millisecond change in the
Stim.-T interval.
It has been recommended (Ursula Gebhardt-Seehausen, 1985
and De Jongste et al.f 1985), that the slope to be
programmed-in should be derived from the recorded change
in the Stim.-T interval ( &Stim.-T) from a given
alteration in the paced- rate ( 8Paced-Rate):
Slope = 8Paced-Rate/8 Stim.-T interval.
The ability of this method to provide suitable slopes was
tested by determining the correlation between slopes
predicted by linear regression equations describing the
paced-ventricular rate/Stim.-T interval relations at rest
with programmed slopes arrived at by trial and error,
which resulted in satisfactory rate changes during
exercise, all other programmable indices remaining
unaltered. This exercise was performed twice in each of
10 patients.
Upper Rate Limit:
The maximum programmable upper rate limit with TX "ON" is
between 123 and 142 beats per minute. The pacemaker
algorithms are such that the exact value of the upper rate
limit that can be programmed-in is affected to a small




ATRIAL SYNCHRONIZED VENTRICULAR PACING MODE
COMPARED WITH FIXED-RATE VENTRICULAR PACING MODE
Resting Haemodynamic Studies:
There was a significant improvement in cardiac output and
mean arterial pressure on changing from atrioventricular
block at patients ' intrinsic rate to asynchronous
ventricular pacing at 70 beats per minute with a further
improvement on programming to atrial synchronized
ventricular pacing (Table XXVII).
No significant corresponding changes were observed in mean
pulmonary arterial or pulmonary diastolic pressures
(Table XXVII).
Heart Rate and Arterial Systolic Pressure Changes During
Exercise:
There was a significantly greater increase in systolic
pressure with each stage of the Bruce protocol and during
the immediate post-exercise period during atrial
synchronized ventricular pacing mode as compared with
asynchronous ventricular pacing at 70 beats per minute, as
shown in Figure 19.
Hypotension was an important limiting factor in 11
patients during asynchronous ventricular pacing, but
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occurred in only 3 of the same patients (less pronounced
in 2 patients) during atrial synchronized ventricular
pacing mode (Figure 20).
There were smaller increases in atrial rate with atrial
synchronized ventricular pacing compared with asynchronous
ventricular pacing mode for each exercise stage, as shown
in Figure 19.
Improvement in Exercise Performance Attributable to
Atrial Synchronized Ventricular Pacing Mode:
Exercise performance during atrial synchronized
ventricular pacing mode was better in 59/67 paired
exercise tests and in 30/35 patients. This amounted to
more than 33 percent increase in work done in 23/35
patients and 50 percent or more in 14/35 patients.
The mean ( + 1 S.D.) improvement in exercise performance in
the 35 patients was 45 ( + 39) per cent, range: -12 percent
to +160 percent (Figure 21).
In 20 patients who had two sets of exercise tests, the
improvement in exercise performance with atrial
synchronized ventricular pacing increased from a mean of
18 percent to 48 percent with the passage of time, the
interval between the two tests was 5+2 weeks
(mean + 1 S.D.) and the range was 2 to 12 weeks as shown
in Figure 22.
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Calculation of the total distances walked on the treadmill
on the two occasions, in this group of patients showed
that by comparison, exercise performance during
asynchronous ventricular pacing had changed little during
the same period of time (Figure 23).
Frequency of Factors Limiting Exercise Performance in
the Two Pacing Modes (V00 And VAT):
Exercise-induced ventricular arrhythmias, hypotension,
lightheadedness and angina occurred more frequently during
asynchronous ventricular pacing mode (Figure 20).
Exercise during atrial synchronized ventricular pacing
mode was associated with fewer untoward effects, being
limited most commonly by exhaustion, leg fatigue and
dyspnoea, symptoms which occurred as frequently and with
the same or greater severity (indicated by the patient)
during fixed-rate ventricular pacing, despite the shorter
distances walked in this pacing mode.
Comparison of Changes in Haemodynamic Indices with
Improvement in Exercise Performance:
There was no correlation between the magnitude of changes
in resting haemodynamic indices and improvement in
exercise performance due to atrial synchronized
ventricular pacing mode in the 28/35 patients for whom













































































R II III IV R
TREADMILL STAGES
n-^ = Number Of Exercise Tests
n2 = Number Of Patients
• • = VOO Pacing Mode
* x = VAT Pacing Mode
R = PRE—EXERCISE
R'= IMMEDIATE POST-EXERCISE
• p<0 . 05 ••p<0.01 ••• p<0 .002
Figure 19. Exercise-induced atrial rate and systoli
arterial pressure responses during fixed














































































SYMPTOMS LIMITING EXERCISE TESTS
Figure 20. Frequency of symptoms limiting exercise
performance during fixed-rate (V00) and





























































Figure 21. Maximum improvement in exercise performance
during atrial synchronized ventricular (VAT)
pacing mode (expressed as per cent of exercise
performance during fixed-rate ventricular



































< 1 WEEK >2 WEEKS
POST - IMPLANT PERIOD
Figure 22. Comparison of changes in exercise performance
due to VAT pacing mode in 20 patients who had
two sets of exercise tests, separated by
several weeks.
Individual data and mean +1 SD for the sets
of exercise tests.
0-J FR VAT FR VAT
<1 WEEK >3 WEEKS
POST IMPLANT PERIOD
Comparison of distances walked during fixed-
rate (V00) and atrial synchronized (VAT)
ventricular pacing modes, in 20 patients who



























































0 10 20 30 40 50 60 70
PER CENT CHANGE IN CARDIAC OUTPUT
WITH VAT PACING
Figure 24. Correlation of changes in cardiac output
recorded at pacemaker implantation, with
changes in exercise performance due to atrial


































































0 10 20 30 40 50 60
MAXIMUM MEAN SYSTOLIC ARTERIAL
PRESSURE (miriHg) CHANGES WITH
VAT PACING
Figure 25. Correlation of changes in mean systolic arterial
pressure recorded at rest with changes in




























































0 10 20 30 40 50 60 70 80
MAXIMUM PULSE PRESSURE (mmHg) CHANGES
DURING V00 PACING
Figure 26. Correlation of changes in arterial pulse pressure
during fixed-rate, 70 beat per minute (VGO)
pacing recorded at rest, with changes in































































10 20 30 40
PULMONARY DIASTOLIC PRESSURE (mmHg)
DURING VOO PACING
Figure 27. Correlation of pulmonary diastolic pressures
recorded during fixed-rate, 70 beats per minute
(VOO) pacing mode at rest, with changes in
exercise performance due to atrial synchronized
ventricular pacing mode.
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B. ATRIAL SYNCHRONIZED VENTRICULAR PACING: CONTRIBUTION
OF CHRONOTRPIC RESPONSE TO IMPROVEMENT IN EXERCISE
PERFORMANCE
Comparison of Exercise Performance During Atrial
Synchronized (VAT), Chest Wall Stimulation Triggered
(V-CWS-T) And Fixed Rate Ventricular Pacing Modes:
The rate of chest wall stimulation throughout exercise
during V-CWS-T was 2.5+3 (mean + 1 SD) pulses per minute
higher than the corresponding atrial rate. This
represented only a fraction of the total heart rate
changes recorded during exercise.
Exercise performance was significantly improved during
V-CWS-T and VAT modes as compared with that during V00
mode (Tables XXVIII and Figures 28 and 29). Exercise
performance during V-CWS-T mode, however, was similar to
that during VAT mode (Table XXIX and Figures 28 and 29).
Atrial rates were higher (Figure 30), and systolic
arterial pressures lower (Figure 31) during VOO mode as
compared with V-CWS-T and VAT modes, for each stage of the
Bruce protocol and during the immediate post-exercise
period. There were no corresponding significant




































V00 V-CV/S-T VAT VOO V-CV/S-T VAT
Pacing Mode
Figure 28. Comparison of total distances walked during
fixed-rate, 70 beats per minute (VOO), atrial
synchronized (VAT) and chest wall stimulation































































Figure 29 . Comparison of exercise performance
during atrial synchronized (VAT) and chest wall
stimulation triggered (V-CWS-T) pacing modes,
(expressed as per cent of exercise performance
during fixed-rate ventricular pacing mode).
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Arterial systolic pressures were on average higher during
V-CWS-T than VAT mode (Figure 31), but the heart rates
were slightly higher (mean + 1 SD; 4+3, beats per
minute) in V-CWS-T pacing mode.
The frequency of parameters limiting exercise duration is
shown in Figure 32. Lightheadedness, postural
hypotension, and premature ventricular complexes
complicated V00 mode more frequently than V-CWS-T and VAT
modes. Symptomatically the patients did equally well in






















































STAGES OF BRUCE PROTOCOL
NS
• = VOO, X = V-CWS-T, o = VAT R = Pre-Exercise
*■* p <0.01 ***p<0.002
NS = Not significant
R = Immediate post-Exercise
number of patients
Figure 30. Atrial rate responses to exercise
during fixed-rate (VOO), atrial synchronized
(VAT) and chest wall stimulation triggered
(V-CWS-T) pacing modes.








































STAGES OF BRUCE PROTOCOL
• = VOO, X = V-CWS-T, O = VAT R = Pre-Exercise
* p<0.05 **p<0.01 *** p ^0.002 R1 = Immediate post-Exercise
NS = Not significant
Figure 31 . Systolic arterial pressure responses
to exercise during fixed-rate (VOO), atrial
synchronized (VAT) and chest wall stimulation

























Figure 32. Frequency of symptoms limiting
duration of exercise tests during fixed-rate
(VOO), atrial synchronized (VAT) and chest
wall stimulation triggered (V-CWS-T) pacing
modes.
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C. STUDIES INVOLVING THE TX PACING SYSTEMS
(i) Comparison of Exercise Performance During Fixed-
Rate Ventricular (V00 and VVI), Atrial Synchronized
Ventricular (VAT_)__ And Rate Responsive (TX) Pacing Modes :
VAT Mode Versus V00 Mode:
The total distances walked on the treadmill during atrial
synchronized ventricular pacing mode were significantly
(p<0.01) greater than those achieved during fixed-rate
ventricular pacing at 70 beats per minute pacing mode,
(Figure 33);
Mean + 1 S.D. distance during VOO mode:
468 + 279 yards (range, 183 to 937 yards).
Mean + 1 S.D. distance during VAT mode:
689 + 384 yards (range, 261 to 1356 yards).
The ventricular rate at maximal exercise during atrial
synchronized ventricular pacing mode was 148 + 15 beats
per minute (mean + 1 S.D.).
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Rate Responsive (TX) Mode Versus
Ventricular Demand Mode:
The total distances walked on the treadmill during TX
and VVI, 70 beats per minute, pacing modes are shown in
Figure 33;
Mean + 1 S.D. distance walked during the VVI mode:
539 + 387 yards (range, 33 to 1329 yards).
Mean + 1 S.D. distance walked during the TX mode:
750 + 435 yards (range, 99 to 1490 yards).
Exercise performance during the rate responsive mode was
significantly (p<0.002) greater than that during
ventricular demand pacing at 70 beats per minute.
The ventricular rate at maximal exercise during TX pacing
mode was 124 + 9 beats per minute (mean + 1 S.D.).
The tracking mode was observed on one occasion in a
patient with congenital heart block whose spontaneous
heart rate accelerated with exercise (Figure 34).
Figure 33. Comparison of exercise performance during fixed-
rate (V00) and atrial synchronized (VAT) pacing
modes pre-pacemaker implantation and exercise
performance during VAT and rate responsive (TX)
























(ii) Performance of the TX Pacemaker as Assessed by
Hoiter-Monitoring:
The rate changes during 24 hours of Holter monitoring are
illustrated in Figures 35 to 38.
The rate remained appropriately low during periods of
inactivity such as sleep and accelerated during periods of
increased activity.
On 2 occasions in the same patient however, the rate
accelerated during the night without the patient reporting
any increased activity (Figure 36). It remained uncertain
whether these episodes represented inappropriate rate
responses or were related to dreaming or activity for
which the patient had no recollection. The patient
however did not complain of palpitations or any other form
of discomfort and the pacemaker programme was therefore
left unaltered.
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Figure 35. Example of 24 hour Holter recording in a
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Figure 36. Example of 24 hour Holter recording in a




















Figure 37. Example of 24 hour Holter monitoring in a




































Figure 38. Example of 24 hour Holter monitoring




(iii) The Paced-Ventricular Rate/Stim.-T Interval
Relation - Curve Fitting:
The Stim.-T intervals obtained at rest for each
paced-ventricular rate on each occasion are shown in
Table XXX.
A very close correlation existed between the paced-heart
rate and the Stim.-T interval for each occasion that this
relation was examined.
The correlation coefficients of exponential, logarithmic
and power curve, regression equations on 24 separate
occasions are compared in Table XXXI. The differences
between the various correlations of coefficients were
small. The best fit however was provided by the power
curve regression equation on 14 occasions, logarithmic
equation on 7 occasions and exponential equation on 2
occasions. On 2 occasions, power curve and logarithmic
regression equations provided jointly the best curve fit.
At each heart rate, there was a marked variation in
Stim.-T interval (Figure 39).
For the group a linear regression equation described the
rate/Stim.-T interval relation equally well: (Figure 39)
Stim.-T Interval (ms) = 466 - 1 . 68 x Paced-Rate (bpm),
r = -0.84.
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(iv) The Paced-Ventricular Rate/Stim.-T Interval Relation
- Inter-Patient and Intra-Patient Variation:
The paced-rate/Stim.-T interval relation was subject to
significant inter-patient (Figure 40) and intra-patient
(Figure 41) variation.
Consequently, the regression equations describing the
paced-rate/Stim.-T interval, predict that a given change
in the Stim.-T interval would be produced by different
heart rates. For example, a 100 ms reduction in the
Stim.-T interval is predicted to occur as the result of an
increase in heart rate from 70 to 109 beats per minute in
patient 6 compared with 70 to 203 beats per minute in
patient 11 and 70 to 130 beats per minute in patient 4 on
one occasion and 70 to 180 beats per minute on another
occasion (Figure 42).
This finding further indicates that the workloads which
are necessary to trigger the sensor and to achieve the
upper rate limit will vary from patient to patient and in
the same patient from one occasion to another.
This was observed in practice in 3 patients who underwent
exercise testing on more than one occasion using identical
exercise protocols and programmed settings.
Figure 43, 44 and 45 show that the onset of rate
response and the time taken to achieve the upper rate
limit varied on different occasions in the same patient,
despite identical programmed parameters and similar atrial
rate responses (and hence presumbably comparable states of















50 60 70 80 90 100 110
PACED- VENTRICULAR RATE
(b.p.mj
Regression lines describing the
paced-ventricular rate/Stim.-T interval
relation in S patients.
Figure 41. Heart rate/Stim.-T relation on 5 separate
occasions in the same patient.
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(v) Comparison of Paced-Ventricular Rate/Stim.-T,
Paced-Ventricular Rate/Stim.-T(Apex) and Paced-
Ventricular Rate/Stim.-T(SE) Relations:
The results of the comparison between the
paced-ventricular rate/Stim.-T relation, derived from
values provided by the computer, and the paced-ventricular
rate /Stim.-T(apex) and paced-ventricular rate/Stim.-T(SE)
relations derived from surface electrocardiogram are shown
in Table XXXII.
1. T waves were sensed just short of the Stim.-T(Apex)
in 3/5 patients and in one patient the Stim.-T and
the Stim.-T(Apex) were very similar.
2. In 11/15 cases the slopes of the regression equations
describing the heart rate/Stim.-T and the heart
rate/Stim.-T(Apex) were also very similar, because
of the proximity of the Stim.-T intervals to the
corresponding Stim.-T(Apex) intervals.
3. There was no agreement between the slopes of the
heart rate/Stim.-T(SE) regression equations and those
of the heart rate/Stim.-T and heart rate/Stim.-T(Apex)
equations in 12/15 cases. The slopes of the heart
rate/Stim.-T(SE) equations in these patients were
steeper than those describing the heart rate/Stim.-T














































(vi) Effect of Changes in Certain Programmable Parameters
on the Performance of the TX Pacemaker:
1A) T Wave Sensing:
Sensing problems arose in 3 patients. In one patient with
a Quintech model (J. Mc.), this was overcome by reducing
the pacemaker output from 5.0 V to 2.5 V, presumably
through a reduction in the afterpotential. In a second
patient spontaneous recovery of T wave sensing occurred 5
months following pacemaker implantation. In the remaining
patient T wave sensing has remained unsatisfactory.
In the last patient to undergo pacemaker implantation
the ability of the TX pacing system to sense T waves was
tested successfully during operation using an external
device which incorporated the pacemaker's sensing
circuit.
(B) Changes in T Wave Amplitude:
There was a progressive increase in the amplitude of the
sensed T wave with increasing paced-ventricular rate
(Figure 46).
(C) T Wave Sensitivity:
Although T wave sensitivity was programmable between 0.5
mV to 5.0 mV in intervals of 0.5 mV, in 12/13 patients T






































































'—• ventricular rate ^onset of rate response
•*—+ atrial rate ^upper rate limit
Figure 43. Atrial and paced-ventricular rates during
exercise on 4 separate occasions in a patient whose































































—• ventricular rate onset of rate response
—^atrial rate 4^ upper rate limit
0 10
Figure 44. Atrial and paced-ventricular rates during
exercise on 3 separate occasions in a patient whose
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Figure 45. Atrial and paced-ventricular rates during
exercise on two separate occasions in a patient whose
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Figure 46. Changes in T wave amplitude with increasing
paced-ventricular rate recorded in patients
with implanted TXl pacemaker.
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rest using the HP-85, over a paced-ventricular rate of 40
to 110 bpm by programming to T wave sensitivities of 1.5
mV or less.
The quality of T wave sensing was affected by the
programmed paced-ventricular rate. T wave sensing was
usually less satisfactory at extremes of a heart rate
range.
(D) Chronic Changes in T Wave Sensing:
Changes in T wave sensing with the passage of time were
not formally tested in the immediate post-operative period
as most of our patients were switched on to a TX mode
after two weeks.
Satisfactory T wave sensing probably occurs earlier than
this in some patients. In one patient (M.D.) with a
Quintech generator, no T wave sensing occured at a T wave
sensitivity of 1.0 mV and a variable T wave sensing at a
programmed T wave sensitivity of 0.5 mV, 7 days following
pacemaker insertion. The quality of T wave sensing
improved in the subsequent week:
Pacemaker implant
Date - 3003<84
Paced-Rate (bpm) 50 60 70 80 90 100
Date - 060484
%T waves sensed Nil 0-50 80 97-100 100 95-100
Date - 130_4_84
%T waves sensed 30-80 100 100 99-100 100 100
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T wave sensing was also observed to deteriorate in some
patients. For example, patient H.B. lost T wave sensing
over all paced heart rates (50 to 120 bpm), 8 months after
pacemaker implantation at a programmed T wave amplitude of
1.0 mV. Adequate T wave sensing however was restored by
programming to a T wave sensitivity of 0.5 mV.
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(E) Effect of T Wave Sensitivity on the
Heart Rate/Stim.-T Interval Relation:
Altering the T wave sensitivity affected:
(i) The paced-ventricular rate/Stim.-T interval
relation, (Figures 47, 48 and 49) and
(ii) The rate of onset of rate response and time taken
to attain the upper rate limit (Figures 50 and 51).
Figure 49. Paced-ventricular rate/Stim.-T interval
relation derived at two different T wave sensitivities
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Figure 47. Paced-ventricular rate/Stim.-T interval
relation derived at 3 different T wave
sensitivities in a patient (A).
Figure 48. Paced-ventricular rate/Stim.-T interval
relation derived at two different T wave sensitivities
in a patient (B).
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4' Onset of rate response
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X—x Atrial rate
••—•• Ventricular rate
Figure 50. The effect of two differing T wave sensitivities
on the paced-ventricular rate responses during identical
exercise tests in a patient (A) in whom all other programmed
parameters were unaltered.




















































T Wave Sensitivity - 1.0 mV
I *





1 2 3 4 5 6
EXERCISE TIME (min)
0 1 2 3 4 5
POST-EXERCISE (min)
^ Onset of rate response
^ Upper rate limit
X—'X Atrial rate
• .—Ventricular rate
Figure 51. The effect of two differing T wave sensitivities
on the paced-ventricular rate responses during identical
exercise tests in a patient (B) in whom all other programmed
parameters were unaltered.
Figure 52. The varying relation of the Stim.-T interval
to the T wave sensing window during exercise.
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(F) T Wave Sensing Window:
The upper limit of the T wave sensing window was initially
set at a value equal to the Stim.-T interval at paced-
ventricular rate of 70 bpm at rest plus an additional 20
ms ( 'fudge factor').
With experience it became clear that when the T wave
sensing window was set too wide, i.e. equal to or greater
than the Stim.-T interval, rate response often occurred at
rest with the pacing rate frequently reaching the
programmmed upper rate limit (Figures 52 and 53).
Conversely, when the T wave sensing window was
inappropriately short, the Stim.-T interval would not
shorten sufficiently during exercise to permit a rate
response (Figure 54).
Rate response would then occur occasionally in the
recovery period (as illustrated in Figure 55) as the
Stim.-T continued to shorten both due to the presence of
high levels of sympathetic activity, as indicated by the
high atrial rates, and because of the delay which is
necessary for the Stim.-T interval to adapt fully to
changes in heart rate.
When the sensing window was appropriately shorter than the
Stim.-T interval, rate response would occur during
exercise, after an interval of time which depended on the
'Stim.-T interval - sensing window' difference.
Figure 53. The effect of slope and T wave sensing window on
paced-ventricular rates in a patient: Rate
response occurred at rest and heart rate
accelerated to the upper rate limit, at a
programmed slope of 1.6 bpm/ms and a T wave
sensing window of 400 ms (measured Stim.-T
interval at 70 bpm was 350ms) response to
exercise: Rate response at rest overcome by
reducing the sensing window; The heart rate
remained high despite halving the slope; Rate
response was abolished by reducing the sensing
window by 50ms with satisfactory rate changes
during exercise thereafter.
Jfc=slope: 1.6 bpm/ms ; sensing window: 200-400 ms
+ =slope: 0.8 bpm/ms ; sensing window: 200-400 ms
o=slope: 0.8 bpm/ms ; sensing window: 200-350 ms
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Subsequently, the maximum heart rate and the time taken to
achieve it would be determined by the programmed slope,
the upper rate limit and the extent to which the Stim.-T
interval shortened i.e.
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Figure 54. Absence of rate response to exercise due to
inappropriately short T wave sensing window
(Exercise A), overcome by increasing the T wave
sensing by 40ms (Exercise B).
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Figure 55. Rate response occurring late with the upper
rate limit achieved in the recovery period of
an exercise test (Exercise A), overcome by




Estimating the slope from calculations based on
paced-ventricular rate/Stim.-T interval relation at rest
frequently resulted in inappropriate rate responses. A
significant correlation did exist however, between
calculated slopes and programmed slopes which were
eventually discovered to provide satisfactory rate changes
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SLOPES DERIVED FROM RESTING
PACED-VENTRICULAR RATE/STIM.-T INTERVAL RELATIONS
(bpm/ms)
Figure 56. Correlation of slopes derived from resting
paced-ventricular rate/Stim.-T interval relations and
programmed slopes which provided satisfactory rate
responses during treadmill exercise tests.
Table XXIII. Pre-operative clinical characteristics of
patients who received atrial synchronized ventricular
pacing systems.
No. Of Patients




Rhythm Chronic 2nc^ degree
A-V block (Mobitz II) 2
Chronic complete A-V Block 33
Aetiology Idiopathic 28
Ischaemic heart disease 3
Congenital 2
Aortic valve surgery 1
Cardiomyopathy 1
Table XXIV. Clinical characteristics of
patients who underwent exercise tests in
V00, VAT and V-CWS--T pacing modes.
Patient Sex Age (yr) Weight (kg)
1. Female 76 61.8
2. Male 60 70.0
3. Male 63 98.6
4. Female 76 59.6
5. Male 70 71.0
6. Male 73 78.0
7. Male 70 68.0
8. Male 71 72.7
9 . Male 62 76.4
10. Female 67 60.0
11. Female 72 57.0
12. Male 73 70.0
13. Male 51 111.4
14. Male 78 50.9
Abbreviations:yr = years; kg = kilograms.
Table XXV. Pacing order in individual
patients.
Occasion
Patient 1st 2nd 3rd
1. VOO VAT V-CWS-T
2. VOO V-CWS-T VAT
3. V-CWS-T VAT VOO
4. VAT V-CWS-T VOO
5 . VAT V-CWS-T VOO
6. VAT V-CWS-T VOO
7. VOO VAT V-CWS-T
8. VOO V-CWS-T VAT
9 . V-CWS-T VOO VAT
10. V-CWS-T VOO VAT
11 . VAT V-CWS-T VOO
12. VAT VOO V-CWS-T
13. V-CWS-T VAT VOO
14. VOO VAT V-CWS-T
Abbreviations:V00 = fixed-rate ventricular
pacing; VAT = atrial synchronized
ventricular pacing; V-CWS-T = chest wall
triggered ventricular pacing.
Table XXVI. Clinical characteristics of patients who
received the rate responsive (TX) pacing system.
Patient Sex Age Rhythm Aetiology
1. I .M. Male 42 rd3 degree AV block Congenital
2. J.M. Female 70 , , Idiopathic
3. H.B. Male 72 , , Idiopathic
4 . J.C. Mai 55 , , Idiopathic
5 . G.L. Male 75 , , Idiopathic
6. J.Mc. Female 53 , , Congenital
7. J.H. Male 66 , , Idiopathic
8. M. D. Female 67 ,, His Bundle Ablation
9. J. B. Male 17 , , Congenital
10 . S.M. Female 24 , , Congenital
11 . J.C. Female 51 , , Idiopathic
12. E.S. Male 58 , , Idiopathic
13. W. S. Male 60 , , Idiopathic























































































Table XXVIII. Comparison of total distances walked
on the treadmill during fixed-rate (V00), atrial
synchronized (VAT) and chest wall stimuli triggered
(V-CWS-T) ventricular pacing modes.
Pacing Mode Distance (m) Mean + 1 SD (Range)
V00 436 + 128
(98 to 894) * *
V-CWS-T 613 + 198





** =p<0.001; NS= Not significant.
Table XXIX. Improvement in exercise performance
during atrial synchronized (VAT) and chest wall
stimuli triggered (V-CWS-T) ventricular pacing
modes compared with fixed-rate ventricular (V00)
mode.
Pacing Mode Mean + 1 S.D. (Range)
V-CWS-T 40 + 24 %
(5 to 85 %) NS
VAT 44 + 31 %
(12% to 140 %)
Abbreviation: NS= Not significant.
Table XXX. Stim.-T intervals recorded at rest at various
paced-ventricular rates in individual patients on separate
occasions.
Pat- Paced-Ventricular Rate (bpm)
ient Date 40 50 60 70 80 90 100 110 120
I.M. 071083 367 334 323 315 306 298 290
101083 360 342 328 315 303 295 286
131083 352 342 329 318 307 301 298
*131083 350 338 325 315 306 296 288
*131083 355 338 326 316 304 296 289
080384 345 3 39 321 309 297 287 276
J.M. 071083 364 342 324 310 295 286 282
141083 383 360 338 321 307 295 288
*141083 390 366 348 328 313 304 297
111183 385 363 338 320 302 296 290
*111183 381 364 346 331 319 300 295
100284 390 369 345 326 310 301 297
*100284 408 385 360 344 325 313 310
130484 364 342 324 310 295 286 282
110584 409 382 355 343 325 307 298
*110584 418 394 373 352 331 313 297
100585 342 303
H.B. 090983 382 361 355 336 326 307 298 288
300983 360 338 324 310 300 287 283
071083 364 342 324 310 295 286 282
021283 394 363 341 324 308 298 290 284
*021283 364 342 334 313 303 296 286
100284 293 290 275
270484 378 357 333 315 300 290 283
250584 326 311 299 284 275
250584 315 297 282 273 264
*250584 299 287 275 266
070684 358 337 319 301 286 274 262
070684 376 349 331 310 295 286 271
100585 312 270
J.C. 181183 403 369 360 351 339 330
-
*181183 428 397 385 376 352 336 329
" A
*181183 392 369 355 341 330
A
161283 429 399 376 357 342 339 327
A
161283 420 390 368 365 353 340 332
A
*161283 444 401 390 381 360 347 344
240184 428 397 385 370 352 336 329
*240184 403 369 360 351 339 330
*100284 420 390 368 365 353 340 332
100284 426 397 380 370 352 337 327
270484 441 411 381 360 339 324 312
270484 363 357 342 336
*270484 439 399 379 347 327 312 297
250584 413 386 362 344 320 308 29 6
*250584 424 394 370 349 331 313
100585 351 300
Table XXX continued:
Pat- Paced-Ventricular Rate (bpm)
ient Date 40 50 60 70 80 90 100 110 120
J. H. 110584 375 351 327 312 291 279 270 261
110584 405 378 354 336 318 303 291
A A
*110584 391 358 334 322 304 287 275
A
010684 415 385 358 340 319 300
G.L. 020384 347 331 325 306 296 288
-
*160384 357 333 321 309 300 291
A
300384 391 355 334 319 301 292 283 280
A
*300384 381 354 330 315 300 291 282 285
A
110584 372 342 332 311 302 293 287
A
*110585 330 317 302 293 290
J.Mc. 030584 447 420 390 363 345 327
-
*030584 427 391 370 352 334
030584 450 426 393 369 357
M. D. 060484 438 411 384 366 351
-
060484 434 401 380 362 350
130484 446 422 398 380 365 353
130484 437 416 389 371 359
180584 443 422 395 377 362 344
A
080684 372 360 345 336 321 312 309
A




W.S. 020484 327 312 300 285 279 270
E. S. 020484 330 315 303 285 267 255 240 237
J.C. 020484 324 288 276 267 264
020484 280 286 295
J.T. 200585 364 343 324 309 295 288 280
200585 371 356 336 324 309 298 292
200585 386 363 344 329 314 306 300
*= post-exercise data; ~ = T wave, 0.5 mV; T wave, 1.0 mV;



















































































































































































































































































































































































Atrial synchronized ventricular pacing maintains the
physiological sequence of cardiac chamber activation and
permits a chronotropic response to exercise in patients
with second or third degree atrio-ventricular block. It
was first introduced by Center et al., in 1963. Since
then, the haemodynamic advantages of this pacing mode
compared to fixed-rate ventricular pacing have been well
recognized. Atrio-ventricular sequential pacing has been
shown to improve resting cardiac output (Center et al.,
1963; Gilmore et al., 1963; Samet et al., 1965; Karlof,
1975; Hartzler et al., 1977 and Sutton et al., 1979),
prevent pacemaker syndrome (Alicandri et al., 1978) and
some arrhythmias (Heiman and Helwig, 1966; Zipes et al.,
1968 and Berkovits et al., 1979).
The development of stable and reliable atrial leads, since
the late 1970s, has brought about a rapid growth in the
number of implanted dual chamber systems. However these
pacing systems are more expensive than ventricular demand
pacemakers and with few exceptions (Scwton et al., 1981;
Cameron et al., 1981) require the insertion of two pacing
leads. They can therefore be more time consuming to
implant and programme and may be associated with an
increased complication rate.
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It is therefore important to ascertain whether
physiological pacing does result in increased exercise
performance - a measure of far greater practical
importance to patients than resting haemodynamic indices.
Few studies have examined this aspect of adaptive pacing.
Kruse and Ryden (1981) published their observations on 16
patients who were exercised on a bicycle ergometer during
atrial synchronous ventricular inhibited and ventricular
demand pacing modes. They found that patients tolerated
greater work loads in the former mode. The improvement in
exercise performance was long-lasting (Kruse et al.,
1982 ) .
The results of a larger study are presented in this
thesis, involving 35 patients with stable high degree
atrio-ventricular block who received atrial synchronized
ventricular pacemakers.
Twenty-eight patients underwent haemodynamic studies at
the time of pacemaker implantation.
On average, resting cardiac output increased by 28 per
cent as the cardiac rhythm changed from a slow spontaneous
ventricular rate to ventricular pacing at 70 beats per
minute. Atrial synchronized ventricular pacing resulted
in further improvement of cardiac output by 22 per cent.
There were small but significant corresponding increases
in the mean systolic arterial pressure.
Exercise performance during atrial synchronized
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ventricular pacing was compared with fixed-rate
ventricular pacing at 70 beats per minute, in studies
involving all 35 patients.
The importance of performing such studies as double-blind
as possible cannot be overemphasized. The treadmill was
chosen in preference to the bicycle ergometer as it is
more akin to most patients' daily activities.
Most patients improved their exercise performance on
changing from fixed ventricular pacing at a rate of 70
beats per minute to atrial synchronized ventricular
pacing. This was substantial in the majority of patients
amounting to 33 per cent or more in 23/35 patients.
In 20 patients who had two sets of exercise tests, average
exercise performance increased from 18 per cent, recorded
soon after institution of atrial synchronized ventricular
pacing mode, to 48 per cent about five weeks later.
In addition, atrial synchronized ventricular pacing
reduced the incidence of exercise-induced hypotension and
lightheadedness and arrhythmias. Furthermore, the greater
increases in blood pressure and lesser increases in atrial
rate indicated that cardiac output during exercise was
higher during this pacing mode.
An interesting observation was significantly higher atrial
rates for each stage of the exercise protocol with
fixed-rate ventricular pacing, indicating that this pacing
mode was accompanied by a higher sympathetic activity.
Additionally, the greater increases in systolic arterial
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pressures during exercise with atrial synchronized
ventricular pacing mode suggested that cardiac output
during exercise was greater with this pacing mode.
These observations have subsequently been confirmed by
others (Perrins et al., 1983 and Yee et al., 1984).
It has been suggested that ischaemic heart disease may be
a contraindication to physiological pacing, as the
increased heart rate may induce angina (Karloff, 1975).
It is noteworthy in this context that three of our
patients developed angina in fixed-rate ventricular pacing
mode but not during atrial synchronized ventricular pacing
mode, despite longer distances walked in the latter pacing
mode. This finding of an increased tendency to develop
angina during non-physiological pacing in patients with
ischaemic heart disease may be explained by the presence
of increased sympathetic nervous system activity.
As it may not be possible for economic reasons for all
patients with complete heart block to receive atrial
synchronized ventricular pacing systems, it would be
convenient to have a simple method which identifies
pre-operatively patients who would benefit most from this
pacing mode.
Edhag et al. (1981) reported that variations in pulse
pressure during fixed-rate ventricular pacing may indicate
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patients who would benefit from physiological pacing.
Reiter and Hindman (1982) have also described the
existence of a good correlation between the percentage
increase in pulse pressure by fortuitous atrial and
ventricular synchrony (i.e. PR interval of 100 to 200 ms)
during ventricular pacing, and the change in cardiac index
achieved subsequently by atrioventricular sequential
pacing. Unfortunately, we (Fananapazir et al., 1983b)
could not find a correlation between changes in resting
haemodynamic indices and the degree to which exercise
performance improved with adaptive pacing. Pehrsson and
Astrom (1983) have confirmed that aortic pressures at rest
do not predict the magnitude of increase in cardiac output
during exercise in atrial synchronized ventricular pacing
mode. Others have also shown that age, sex, co-existing
cardiac disease, heart size, systolic time intervals,
echocardiographic data and resting haemodynamic findings
do not separate groups of patients which would benefit
from atrial synchronized ventricular pacing mode (Kruse
and Ryden, 1981; Kruse et al., 1982 and Kristensson et
al., 1983a).
Having established that atrial synchronized ventricular
pacing was of practical value to most patients with a high
degree of atrioventricular block, the studies were
extended to examine the separate contributions of
atrioventricular synchrony and chronotropic response to
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improvement in exercise performance during atrial
synchronized ventricular pacing mode, on a within-patient
and double-blind basis. That heart rate was the more
important factor was suggested by the observation that two
patients with congenital heart block, who spontaneously
increased their ventricular rates during exercise, did not
benefit from physiological pacing (Fananapazir et al.,
1983b).
To unravel the problem patients were exercised in three
pacing modes: first, fixed-rate ventricular pacing at 70
beats per minute; second, atrial synchronized ventricular
pacing mode where chest wall stimuli were used to provide
a rate response in the absence of atrioventricular
synchrony and third, atrial synchronized ventricular
pacing mode. Exercise performance was significantly
increased during the pacing modes which provided a
chronotropic response to exercise compared with fixed-rate
ventricular pacing mode. On average, exercise performance
during asynchronous ventricular pacing, where heart rate
was increased to approximate atrial rate, was similar to
that during atrial synchronized ventricular pacing mode.
Rate augmentation rather than proper sequence of atrio¬
ventricular contraction therefore accounted for most of
the improvement in exercise performance which occurred
during atrial synchronized ventricular pacing mode.
(Fananapazir et al., 1983c)
This study supported the observations of Karloff (1975)
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that at matched pacing rates of 120 beats per minute,
almost identical work loads and cardiac outputs are
achieved by atrial synchronized and fixed-rate ventricular
pacing modes, and Knudson (1982) and MacCarter (1982) who
reported that considerable increases in exercise
performance and cardiac output could be achieved by
appropriately increasing the asynchronous ventricular
pacing rate in response to physical activity.
Pehrson and Astrom, (1983) and more recently Kristensson
et al., (1985), have also independently shown that the
difference in exercise performance between fixed rate
ventricular and atrial synchronized ventricular pacing
modes is largely due to the capability to increase heart
rate in the latter mode.
The contribution of heart rate and properly timed atrial
systole to optimal cardiac output differs at rest from
that during exercise. At rest, atrial contraction
increases cardiac output by about 20 to 25 per cent
(Braunwald and Fram, 1961, Samet et al., 1965 and Martin
and Cobb, 1966) by augmenting stroke volume. The atrial
contribution to resting cardiac output varies with heart
rate (Samet et al. 1966) and depends on the state of the
myocardium. It is reported to be of particular importance
to patients with noncompliant ventricles (Snell et al.,
1966; Chamberlain et al., 1970; Rahimtoola et al., 1975;
Johnson and Daily, 1975). Heart rate, on the other hand,
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may vary within wide limits at rest without haemodynamic
consequences (Stein et al., 1966) as a result of
compensatory changes in stroke volume.
It was originally thought that properly timed atrial
contractions were more important in failing hearts than in
those with normal hearts (Benchimol et al., 1965).
However in failing hearts the left ventricular
end-diastolic pressures are already high and with the
heart operating at the flat end of Frank Starling's curve,
the atria contribute relatively less to stroke volume
(Greenberg et al., 1979).
Oxygen consumption during exercise may increase from 0.25
litres per minute to 3 to 4 litres per minute. This is
achieved through enhanced oxygen extraction,
redistribution of blood flow to muscles and most
importantly, through an increase in cardiac output. This
increased cardiac output is achieved largely through rate
augmentation, especially in patients with diseased
ventricles who have a limited capacity to improve stroke
volume during exercise (Kelman, 1977). Increased venous
return due to the pumping action of muscles and to deeper
and more rapid breathing and increased random atrio¬
ventricular sequence further diminish the need for
provision of properly timed atrial contraction during
exercise by the pacing system.
These findings form a rational basis for pacing systems
that respond to changes in an indicator of physiological
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need by altering heart rate without atrio-ventricular
synchrony and hence the interest in the rate responsive TX
pacemaker. This pacing system relies on the principle
that the QT interval shortens during exercise. Using a
conventional ventricular lead it paces the right ventricle
and senses the T wave of the evoked response. Changes in
the Stimulus-to-sensed T wave (Stim.-T) interval indicate
physiological needs, to which the pacemaker responds by
altering the paced-ventricular rate (Rickards and Norman,
1981; Rickards et al., 1981; Rickards and Donaldson, 1983;
Rickards et al., 1983).
Donaldson et al. (1983a-c) reported their experience with
this pacemaker in 5 patients. Pharmacologically induced
changes in rate were obtained soon after implantation of
the pacemaker with administration of isoprenaline in
boluses of 2 ug intravenously (the slope was set at 0.5
bpm per ms). Stim.-T interval shortening was documented
by an HP-85 computer and increases in heart rate from
electrocardiographic recordings. Exercise testing was
performed in each patient during ventricular demand pacing
at 70 beats per minute and rate responsive pacing (with a
maximal rate set at 125 beats per minute). Cardiac output
was measured in triplicate both at rest and at peak
exercise with both modes of pacing by the thermodilution
technique. Holter monitoring was also performed on the
patients over periods of 24 hours.
With isoprenaline the maximal rate of 125 beats per minute
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was achieved around three and a half minutes after
infusion which then fell gradually over the next 6
minutes. The Stim.-T interval decreased from 340 ms to
320 ms after 2 minutes of isoprenaline infusion.
There was a smooth and progressive rate response to
exercise and a gradual return to the basic paced rate
after activity stopped. Rate responsive pacing resulted
in a 45 per cent increase in cardiac output when compared
with fixed-rate ventricular pacing. Similarly, a 57 per
cent increase in maximal exercise capacity was noted when
rate responsive pacing was compared with conventional
pacing at 70 beats per minute.
Comparison of exercise performances during TX rate
responsive, atrial synchronized and fixed-rate ventricular
pacing modes confirmed our previous finding that adaptive
pacing significantly improved exercise performance largely
through an increase in heart rate. Thus in this respect
the TX pacing system compares favourably with pacemakers
which combine atrio-ventricular synchrony with the ability
to provide a chronotropic response to exercise.
The incidence of inadequate T wave sensing has been
estimated to have been about 18 per cent (63/350 implanted
units) with the TXl but only 3.6 per cent (9/251 implanted
units) with the introduction of the Quintech model
(Vitatron Medical, October 1984).
T wave sensing may deteriorate with the passage of time.
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Fortunately in our series a change in the programmed T
wave sensitivity in most instances ensured adequate rate
changes. Reprogramming T wave sensitivity however may
upset the rate/Stim.-T interval relation and may require
adjustments of the slope and T wave sensing window.
The amplitude of the sensed T wave was noted to increase
with higher pacing rates. This may be explained by the
observation that action potentials are longer in
endocardial than in epicardial muscle (Moore et al.,
1965). Gradients of endocardial-to-epicardial
transmembrane action potential therefore exist which may
determine the configuration of the T wave and which in
turn may be affected by heart rate.
As the heart rate/Stim.-T interval relation depends in
part on the T wave configuration and amplitude, this
relation therefore probably changes constantly during
exercise. This in turn may explain the finding that the
heart rate/Stim.-T (dependent on T wave configuration) and
heart rate/QT interval relations conform to different
regression equations.
Additional problems with the TX pacing system which were
identified included:
Firstly, the complexity of programming. (a) Several
factors simultaneously affect the paced-ventricular
rate/Stim.-T interval relation and hence the
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quality of rate responsive to a given work load as judged
by the onset of rate acceleration and the time interval
taken to reach the programmed upper rate limit during an
exercise test. These include the individual's state of
autonomic nervous system activity, changes in T wave
sensing, programmed T wave sensitivity, T wave sensing
window and lower and upper rate limits. (b) The HP-85
programmer is cumbersome, expensive and difficult to
operate.
Secondly, assuming that a satisfactory programme is one
that provides the patient with rate responses during
periods of activity only, there is a great deal of
uncertainty as to the best method which would determine
such a programme. This study indicates that the
suggestion (Ursula Gebhardt-Seehausen, 1985 and de Jongste
et al., 1985) that this can be achieved by adjusting the
programmed slope, based on the Stim.-T interval changes
occurring at rest and in response to alterations in the
pacing rate may not always provide appropriate slopes.
There may be several reasons for this, namely (a) the
paced-ventricular rate/Stim.-T interval relation is not
linear but curvilinear, (b) the timing of rate changes are
affected as much by the T wave sensing window as the
programmed slope and (c) the factors affecting the Stim.-T
interval at rest may be different to those operating
during exercise: at rest, heart rate predominantly
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determine the Stim.-T wave interval, whilst during
exercise both heart rate and autonomic nervous system
activity contribute to Stim.T interval changes. It is
therefore not surprising that predicted slopes derived
from resting heart rate/Stim.-T interval relations in many
instances did not provide for satisfactory rate responses
during exercise tests.
Thirdly, the reliability of the Stim.-T interval as a
biosensor, and ultimately the performance of the TX
pacemaker, is affected by the variable nature of the
relation between heart rate and the Stim.-T interval, and
in this respect the paced-ventricular rate/Stim.-T
interval relation behaves very similarly to the heart
rate/QT interval relation. The duration of the Stim.-T
interval depends on the pacing rate as well as the state
of autonomic nervous system activity. Hence in the
interaction of heart rate, circulating catecholamines,
vagal and left and right sympathetic nervous system
activity and their variable contributions to Stim.-T
changes may be found the explanation for the wide inter-
and intra-patient variation exhibited by the
paced-ventricular rate/Stim.-T interval relation. This
patient variation is potentially the most serious
limitation of this biosensor, as it indicates that not
only will the programme have to be tailored to individual
needs but that more seriously, the same programme may give
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rise to unpredictable results. After achieving seemingly
satisfactory rate responses through programming,
inappropriate rate acceleration may occur at rest as a
result of minimal Stim.-T interval shortening due to an
increase in the slope of the heart rate/Stim.-T interval
relation or alternatively vigorous exercise resulting in a
large reduction in the Stim.-T interval, may result in
ineffective rate acceleration due to a reduction in the
slope of the heart rate/Stim.-T interval relation.
Preliminary experience (Fananapazir et al., 1985a and
1985b) suggests that this does occur in practice in some
patients.
Fourthly, programming difficulties are further compounded
by the fact that after a stress test undertaken to
determine the appropriateness or otherwise of a certain
programmed parameter, the autonomic nervous system status
of the patient and hence the heart rate/Stim.-T interval
relation are automatically altered. It may therefore be
necessary to test the effect of further changes in the
programmed indices at a later date.
The following was found to be the quickest and most
convenient method of obtaining a programme which provided
for satisfactory rate responses during exercise but
avoided inappropriate rate augmentation at rest: It
relies on the principle that satisfactory results are
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obtained if the pacing rate remains at the basal rate at
rest and rises only during periods of exertion.
This can be achieved in most patients by maintaining the
slope at about 0.6 beats per minute per millisecond change
in the Stim.-T interval, and adjusting only the T wave
sensing window.
The T wave sensing window set at a value 20 ms less than
the Stim.-T interval, measured at the basal rate. Thus
the risks of inappropriately high heart rates at rest are
minimized. The duration of the T wave sensing window may
then be refined further by evaluating the onset of rate
response during exercise - the shorter the duration of the
T wave sensing window in relation to the Stim.-T interval
the greater is the likelihood that rate response will be
delayed during exercise. The duration of the T wave
sensing window is therefore so adjusted that rate response
will occur after about one to two minutes of exercise and
a heart rate of about 120 beats per minute is achieved
smoothly after a further one to two minutes of exercise,
with a smooth fall to the basic rate during the recovery
period. Heart rates in excess of 120 beats per minute
probably do not result in further improvements in exercise
performance and may cause serious haemodynamic problems if
they occur inappropriately at rest.
Fifthly, an important consideration is the large number of
medications, myocardial conditions and metabolic states
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that can affect the QT interval or the Stim.-T interval,
either to shorten it or prolong it (Donaldson and
Rickards, 1982). Any change in the Stim.-T interval would
affect the heart rate/Stim.-T interval relation. It may
be possible in some circumstances, such as with patients
receiving amiodarone (Fananapazir et al., 1985b), to
adjust the programmed sensing window and slope and
maintain satisfactory rate responses. This may be
impracticable in patients receiving drugs with much
shorter half-life or more transient effect on the Stim.-T
interval.
The effect of acute beta adrenoreceptor blocker therapy on
the performance of the TX pacemaker may differ from that
of chronic beta adrenoreceptor blocker therapy.
Preliminary studies indicate that (as expected from the
findings of the first part of this thesis) acute
administration of a beta adrenoreceptor blocker will
severely blunt or abolish rate response to exercise but
that it may be possible to achieve satisfactory rate
changes in patients on chronic beta adrenoreceptor blocker
therapy (Fananapazir et al., 1985b). Further studies are
necessary to confirm these findings.
Given these considerations and until further modifications
of the TX pacing system, our findings suggest that
patients with this pacing system should be followed up
closely, as frequent reprogramming based on results of
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exercise tests and Holter monitoring may be necessary to
adjust for chronic changes in the Stim.-T interval and in
the heart rate/Stim.-T relation and deterioration in T
wave sensing, so as to ensure that the pacemaker continues
to function optimally.
Rate adaptive pacing systems such as the TX pacemakers
should also only be implanted in those patients in whom it
has been clearly shown that the level of exercise
performance is limited by a lack of rate augmentation.
This can be assessed by exercising patients during
fixed-rate ventricular pacing at 70 beats per minute and
during ventricular pacing where the heart rate is
progressively increased to 120 beats per minute, using a
temporary ventricular lead and an external pacing system.
The TX pacing system is hence not indicated in patients
who are inactive and in whom the provision of atrio¬
ventricular synchrony may be more advantagous than high
pacing rates.
Although the development of stable and reliable atrial
leads since the end of the 197 0 's has increased the
popularity of dual chamber pacing systems, these also are
not without their problems. Problems peculiar to these
pacing systems include pacemaker mediated tachycardias
(incidence reduced by the availability of long atrial
refractory periods and post-ectopic increases of
ventricular refractory period), sensing the atrial
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stimulus via the ventricular channel ( 'cross talk'),
myopotential oversensing via the atrial channel of
unipolar systems (facilitated by the use of lower
sensitivity values in the atrial channel but overcome by
using bipolar atrial leads) and shortened service life due
to the need to maintain atrial pacing (aggravated by high
pacing thresholds in the atrium). Additionally, the
various types of universal (DDD) pacing systems which are
available differ importantly in the details of their
programming facilities and there is also a growing
complexity in the analysis of electrocardiographic
recordings obtained with this kind of pacemaker. The
response of a DDD pacemaker to the upper rate limit may be
an important factor in determining exercise performance.
Some pacing systems provide for a 2:1 atrioventricular
response and others permit a Wenchebach-type ventricular
response. The latter upper rate limit response ensures a
less sudden fall in heart rate and is the one we favour as
being least likely to be associated with exertional
lightheadedness.
The advantages of the TX pacing system over universal
(DDD) pacemakers are (a) the use of a single ventricular
lead which facilitates pacemaker implantation and (b) its
suitability in patients with atrial arrhythmias.
The TX pacing system is potentially capable of further
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developments:
Programming could be simplified if the pacemaker design
permits the system periodically and automatically to reset
(a) the duration of the T wave sensing window- the
pacemaker should probably adjust its T wave sensing window
to a value about 20 ms less than the Stim.-T interval
recorded at its programmed lower rate limit, and (b) slope
- the pacemaker would increase its pacing rate to a value
10 to 20 beats per minute higher than the lower rate limit
and reset its slope in response to the magnitude of sensed
change in Stim.-T interval. However this solution
presupposes that there is a direct and constant relation
between slopes obtained in this way by the pacemaker and
the heart rate/Stim.-T interval relation existing during
periods of activity. The evidence is that such a relation
probably exists but may not be sufficiently strong for it
to be of practical value.
How frequently the pacemaker needs to adjust these
parameters will depend on a better understanding of the
diurnal changes in the duration of the Stim.-T interval
and the heart rate/Stim.-T interval relation.
The Stim.-T interval could be used in conjunction with
other biosensors to provide a more comprehensive
indication of metabolic demand.
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Patients with sinoatrial disease may not increase their
heart rate adequately during exercise and in this group of
patients current DDD pacing systems function mostly as an
atrio-ventricular sequential pacing system and the
exercise performance of the patient may remain limited.
In this group of patients the TX principle could be used
to advantage as it may be possible to have a pacing system
which combines DDD functions with rate responsive
capability. During periods of increased physiological
need, the pacemaker would accelerate atrial rate via a
second electrode, in response to changes in ventricular
Stim.-T interval, whilst at the same time ensuring
atrio-ventricular synchrony.
It is therefore envisaged that the TX pacemaker will
continue to evolve rapidly and prove a most useful and
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Figure A. Bazett's cycle length/QT interval hyperbolic
relation.
Figure B. Heart rate/QT interval relations based on the
observations of Rickards and Norman (1981).
Figure C. Electrolyte currents responsible for the
production of the action potential.
Figure D. The effect of beta adrenergic receptor blockade
on the heart rate/QT interval relations based on
the observations of Vaughan Williams (1380 and
1982 ) .
Figure 1. Normal QT intervals.
Figure 2. QT intervals unsatisfactory for measurement.
Figure 3. Measurement of the ventricular effective
refractory period by the extra-stimulus
technique.
Figure 4. Consecutive QT intervals determined following
a change in paced-ventricular rate from 110 to
50 beats per minute in six subjects.
Figure 5. Regression lines describing heart rate/QT
relations during exercise in atrial
synchronized ventricular pacing mode.
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Figure 6. Regression lines describing atrial rate/QT
interval relations during exercise in fixed-
rate, 70 beats per minute, ventricular pacing
mode.
Figure 7. Minimum and maximum contributions made by
factors other than heart rate to QT interval
shortening during exercise tests performed
on two separate occasions.
Figure 8. Patient A; Atrial rate/QT interval and heart
rate/QT interval relations, during exercise
tests, performed during fixed-rate (VOO) and
atrial synchronized (VAT) ventricular pacing
modes, respectively, before and two hours
after an oral dose of a 100 mg atenolol.
Figure 9. Patient B; Atrial rate/QT interval and heart
rate/QT interval relations, during exercise
tests, performed during fixed-rate (VOO) and
atrial synchronized (VAT) ventricular pacing
modes, respectively, before and two hours
after an oral dose of a 100 mg atenolol.
Figure 10. Patient C; Atrial rate/QT interval and heart
rate/QT interval relations during exercise
tests, performed during fixed-rate (VOO) and
atrial synchronized (VAT) ventricular pacing
modes, respectively, before and two hours
after an oral dose of a 100 mg atenolol.
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Figure 11a. Regression lines describing the heart rate/QT
interval relations in the nine normal subjects
during exercise, before beta adrenergic
receptor blockade.
Figure lib. Regression lines describing the heart rate/QT
interval relations in the nine normal subjects
during exercise, two hours after an oral dose
of a 100 mg atenolol.
Figure 12. Comparison of linear regression lines
describing the heart rate/QT interval relations
during exercise in (A) 14 normal subjects, (A')
in 9 subjects before and (B) two hours after a
100 mg atenolol, and (C) in 16 patients who
had taken a 100 mg atenolol daily, for more
than three months and (D) during atrial pacing
at rest in 11 patients.
Figure 13a. QTc changes with increasing heart rates during
exercise in the nine subjects before beta
adrenergic receptor blockade.
Figure 13b. QTc changes with increasing heart rates during
exercise in the nine subjects, two hours after
an oral dose of a 100 mq atenolol.
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Figure 14. Comparison of mean QTc changes with increasing
heart rates during exercise in (A) 14 normal
subjects, (A') 9 normal subjects before and (B)
two hours after an oral dose of a 100 mg
atenolol, and (C) 16 patients who had taken a
100 mg atenolol daily for more than three
months and (D) during atrial pacing at rest.
Figure 15. Linear regression lines describing the paced-
ventricular rate/QT interval and paced-
ventricular rate/VERP relations, in the same
group of subjects.
Figure 16. Ventricular effective refractory period
(VERP)/QT interval relation.
Figure 17. Exercise electrocardiograms during fixed-
ventricular rate (VOO, 70 beats per minute),
atrial synchronised ventricular (VAT) and
chest wall stimulation triggered ventricular
(V-CWS-T) pacing modes.
Figure 18. Diagramatic representation of the 'evoked
response', Stim.-T interval and the T wave
sensing window.
Figure 19. Exercise-induced atrial rate and systolic
arterial pressure responses during fixed
rate (VOO) and atrial synchronized (VAT)
ventricular pacing modes.
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Figure 20. Frequency of symptoms limiting exercise
performance during fixed-rate (VOO) and
atrial synchronized (VAT) ventricular
pacing modes.
Figure 21. Maximum improvement in exercise performance
during atrial synchronized ventricular (VAT)
pacing mode (expressed as per cent of exercise
performance during fixed-rate ventricular
pacing mode). Individual data and mean +1 SD
for the group.
Figure 22. Comparison of changes in exercise performance
due to VAT pacing mode in 20 patients who had
two sets of exercise tests, separated by
several weeks.
Individual data and mean +1 SD for the sets
of exercise tests.
Figure 23. Comparison of distances walked during fixed-
rate (VOO) and atrial synchronized (VAT)
ventricular pacing modes, in 20 patients who
had two sets of exercise tests separated by
several weeks.
Figure 24. Correlation of changes in cardiac output
recorded at pacemaker implantation, with
changes in exercise performance due to atrial







Correlation of changes in mean systolic arterial
pressure recorded at rest with changes in
exercise performance due to atrial synchronized
ventricular pacing mode.
Correlation of changes in arterial pulse pressure
during fixed-rate, 70 beat per minute (VOO)
pacing recorded at rest, with changes in
exercise performance due to atrial synchronized
ventricular pacing mode.
Correlation of pulmonary diastolic pressures
recorded during fixed-rate, 70 beats per minute
(VOO) pacing mode at rest, with changes in
exercise performance due to atrial synchronized
ventricular pacing mode.
Comparison of total distances walked during
fixed-rate, 70 beats per minute (VOO), atrial
synchronized (VAT) and chest wall stimulation
triggered (V-CWS-T) ventricular pacing modes.
Comparison of exercise performance during atrial
synchronized (VAT) and chest wall stimulation
triggered (V-CWS-T) pacing modes, (expressed as
per cent of exercise performance during fixed-
rate ventricular pacing mode).
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Figure 30. Atrial rate responses to exercise during fixed-
rate (VOG), atrial synchronized (VAT) and chest
wall stimulation triggered (V-CWS-T) ventricular
pacing modes.
Figure 31. Systolic arterial pressure responses to exercise
during fixed-rate (VOC), atrial synchronized
(VAT) and chest wall stimulation triggered
(V-CWS-T) pacing modes.
Figure 32. Frequency of symptoms limiting duration of
exercise tests during fixed-rate (VOO), atrial
synchronized (VAT) and chest wall stimulation
triggered (V-CWS-T) pacing modes.
Figure 33. Comparison of exercise performance during fixed-
rate (VOO) and atrial synchronized (VAT) pacing
modes pre-pacemaker implantation and exercise
performance during VAT and rate responsive (TX)
pacing modes following TX pacemaker
implantation.
Figure 34. TX pacemaker performing in the 'tracking' mode in
a patient with congenital heart block whose
spontaneous rate accelerated with exercise.
Figure 35. Example of 24 hour Kolter recording in a
patient (A) programmed to TX pacing mode.
208
Figure 36. Example of 24 hour Bolter recording in a
patient (B) programmed to TX pacing mode.
Figure 37. Example of 24 hour Bolter monitoring in a
patient (C) programmed to TX pacing mode.
Figure 38. Example of 24 hour Bolter monitoring in a
patient (D) programmed to TX pacing mode.
Figure 39. Paced-ventricular rate/Stim.-T relation
at rest.
Figure 40. Regression lines describing the
paced-ventricular rate/Stim.-T interval
relation in S patients.
Figure 41. Beart rate/Stim.-T relation on 5 separate
occasions in the same patient.
Figure 42. Predicted heart rates following a 100 ms
reduction in Stim.-T interval.
Figure 43. Atrial and paced-ventricular rates during
exercise on 4 separate occasions in a patient
whose programmed parameters were unaltered.
Figure 44. Atrial and paced-ventricular rates during
exercise on 3 separate occasions in a patient
whose programmed parameters were unaltered.
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Figure 45. Atrial and paced-ventricular rates during
exercise on two separate occasions in a patient
whose programmed parameters were unaltered.
Figure 46. Changes in T wave amplitude with increasing
paced-ventricular rate recorded in patients
with implanted TXl pacemaker.
Figure 47. Paced-ventricular rate/Stim.-T interval
relation derived at 3 different T wave
sensitivities in a patient (A).
Figure 48. Paced-ventricular rate/Stim.-T interval
relation derived at two different T wave
sensitivities in a patient (B).
Figure 49. Paced-ventricular rate/Stim.-T interval
relation derived at two different T wave
sensitivities in a patient (C).
Figure 50. The effect of two differing T wave
sensitivities on the paced-ventricular rate
responses during identical exercise tests in a
patient (A) in whom all other programmed
parameters were unaltered.
210
Figure 51. The effect of two differing T wave sensitivities
on the paced-ventricular rate responses during
identical exercise tests in a patient (B) in
whom all other programmed, parameters were
unaltered.
Figure 52. The varying relation of the Stim.-T interval
to the T wave sensing window during exercise.
Figure 53. The effect of slope and T wave sensing window on
paced-ventricular rates in a patient: Rate
response occurred at rest and heart rate
accelerated to the upper rate limit, at a
programmed slope of 1.6 bpm/ms and a T wave
sensing window of 400 ms (measured Stim.-T
interval at 70 bpm was 350ms) response to
exercise: Rate response at rest overcome by
reducing the sensing window; The heart rate
remained high despite halving the slope; Rate
response was abolished by reducing the sensing
window by 50ms with satisfactory rate changes
during exercise thereafter.
Figure 54. Absence of rate response to exercise due to
inappropriately short T wave sensing window
(Exercise A), overcome by increasing the T wave
sensing by 40ms (Exercise B).
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Figure 55. Rate response occurring late with the upper
rate limit achieved in the recovery period of
an exercise test (Exercise A) overcome by
increasing the T wave sensing window by 20ms
(Exercise B).
Figure 56. Correlation of slopes derived from resting paced-
ventricular rate/Stim.-T interval relations and
programmed slopes which provided satisfactory
rate responses during treadmill exercise tests.
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